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Mycobacterium tuberculosis infects millions of people every year and in 2015 1.8 million
people died from the disease. The main problem is that M. tuberculosis has a natural
resistance to many antibiotics. Studying of M. tuberculosis is also problematic due to its
high pathogenicity. Mycobacterium marinum is a close relative of M. tuberculosis and the
M. marinum infection in zebrafish resembles closely the human M. tuberculosis infection.
Therefore M. marinum infections on zebrafish have been used as a model for tuberculosis
infections.
When grown in vitro, M. tuberculosis and M. marinum both form biofilms, which har-
bor antibiotic resistant bacteria. The biofilms are believed to be a significant contributor
to the antibiotic resistance these mycobacteria. The biofilms consist of bacteria and the
extracellular matrix and the main components of the extracellular matrix are proteins,
lipids and extracellular DNA. In order to study the effects of the biofilm on the infection
and the antibiotic resistance, biofilm mutant bacterial strains are needed.
The aim of this study was to transduct M. marinum with MycoMar T7 phage and screen
the formed library for strains with abnormal biofilm formation. The overall experiment
consisted of three screens and at each step the seemingly abnormal biofilms were selected.
In the third screen the extracellular DNA and biomass contents were analyzed in reference
to the bacterial count from the selected mutant strains. Crystal violet assay was used to
determine the amount of biomass, DNase I was used to remove the extracellular DNA
and the DNA concentrations were determined with quantitative PCR. The strains with the
most interesting and promising results were then chosen for growth rate determination,
where the growth rate was measured in terms of optical density and bacterial count.
As a result few highly interesting mutant strains were obtained. One of them, 2D,
resembled the wild-type closely, but was unable to form a pellicle. Other very interesting
strain was 8H, which produced significantly higher amounts of biofilm than the wild-type
and also had remarkably low bacterial counts in cultures. Several of the other obtained
mutant strains required more analyses, but could also turn out to be very interesting.
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Mycobacterium tuberculosis infektoi miljoonia ihmisiä vuosittain ja vuonna 2015 1,8
miljoonaa ihmistä kuoli infektioonsa. Suurin ongelma M. tuberculosis -infektioissa on
bakteerin luonnollinen resistenttiys useille antibiooteille. Tuberkuloosin tutkiminen on
myöskin vaikeaa bakteerin korkean patogeenisyyden vuoksi. Mycobacterium marinum on
fylogeneettisesti lähellä M. tuberculosis -bakteeria ja M. marinum -infektio seeprakaloissa
muistuttaa läheisesti ihmisten M. tuberculosis -infektiota. Seeprakalojen M. marinum -
infektioita onkin käytetty mallina tuberkuloosin tautimekanismien selvittämisessä.
In vitro -kasvatuksissa M. marinum muodostaa biofilmiä, jonka sisällä kasvavat bak-
teerit ovat resistenttejä monille antibiooteille. Biofilmin uskotaan osaltaan toimivan suo-
jana antibiootteja vastaan. Biofilmi koostuu bakteereista ja solunulkoisesta matriisista,
jonka tärkeitä komponentteja ovat proteiinit, lipidit ja solunulkoinen DNA. Jotta biofilmin
vaikutuksia infektioihin ja antibioottiresistenttiyteen voidaan tutkia, tarvitaan poikkeavia
biofilmejä muodostavia M. marinum -mutantteja.
Tämän tutkimuksen tavoitteena oli transduktoida M. marinum -bakteereja MycoMar
T7 -faagilla ja siten luoda kirjasto, josta voidaan seuloa poikkeavaa biofilmiä tuottavia
kantoja. Tutkimus koostui kaiken kaikkiaan kolmesta eri seulonnasta ja jokaisessa seu-
lonnassa poikkeavalta näyttävää biofilmiä tuottavat kannat valittiin jatkoon. Kolman-
nessa seulonnassa valikoitujen kantojen solunulkoisen DNA:n ja biomassan pitoisuuksia
analysoitiin ja verrattiin sitten saman kasvatuksen bakteerimäärään. Biomassan määrä
määritettiin kristallivioletilla, solunulkoinen DNA poistettiin DNaasi I:llä ja DNA-pitoi-
suudet kvantitoitiin kvantitatiivisella PCR:llä. Kiinnostavimmista ja lupaavimmista kan-
noista määritettiin niiden kasvunopeudet maljauksen ja absorbanssin avulla.
Lopputuloksena saatiin muutama erittäin kiinnostava M. marinum -kanta. Yksi va-
likoituneista mutanttikannoista, 2D, muistutti muuten villityyppiä, mutta ei tuottanut lain-
kaan pellikkeliä. Toinen kiinnostava kanta oli 8H, joka tuotti villityyppiä huomattavasti
suurempia määriä biofilmiä, mutta jonka bakteerimäärät kasvatuksissa olivat hyvin al-
haisia. Useat muista valikoituneista mutanteista saattavat myös osoittautua kiinnostaviksi
mahdollisten jatkotutkimusten jälkeen.
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11. INTRODUCTION
Tuberculosis is one of the oldest known human diseases. It is caused by Mycobacterium
tuberculosis and in 2015 10.4 million people were infected by M. tuberculosis and 1.8
million died from the disease [1]. The treatment of tuberculosis requires prolonged an-
tibiotic therapy with combination of several different antibiotics. The long regime is of-
ten ended prematurely, which gives rise to multidrug resistant tuberculosis and extremely
drug-resistant tuberculosis [2]. New and more efficient drugs are desperately required for
treatment of the infection.
M. tuberculosis has a natural resistance to many antibiotics and one possible contrib-
utor to this resistance is the biofilm the bacteria form around them. In vitro the biofilm
forming bacteria seem to be more resistant to antibiotics [3]. To study the effects and
components of the biofilm, mutant strains with abnormal biofilms are required.
Since M. tuberculosis is highly pathogenic, Mycobacterium marinum, a close relative
of M. tuberculosis [4], has been used to study the infection mechanisms of tuberculosis
in a safer way. Zebrafish infected with M. marinum can be used as an in vivo infection
model for M. tuberculosis. The biofilms of M. marinum have been studied surprisingly
little, even though it is one of the closest relatives of M. tuberculosis.
The aim of this study is to prepare a library of M. marinum strains with random mu-
tations caused by integration of MycoMar T7 phage and then screen the mutants based
on the appearance of their biofilm. The ones with seemingly abnormal biofilms will be
chosen. At the last stages of the experiment the amount of biofilm per bacteria will be
compared between the mutants and the wild-type M. marinum. The strains with biofilms
clearly different than the wild-type can then be used to study the effects of the biofilm on
infections and resistance to biocides.
The following chapter is about the theoretical background, which first lays the basis
for why this study is important and then moves on to the topics more closely related to
the actual work. The third chapter describes the materials and methods used in this study.
In the fourth chapter the results are presented and discussed simultaneously. This way
the discussion is easier to follow, since the figures related to the results are closer and
therefore easier to find. The last chapter is titled Conclusion and that chapter summarizes
the whole thesis and presents the possible future experiments.
22. THEORETICAL BACKGROUND
This chapter will discuss the theory on which this thesis is based on. The chapter starts
off with M. tuberculosis and its animal models, leading to M. marinum and then to com-
parison of the two bacteria in terms of genetics as well as infection. The chapter ends
with biofilms. They are first discussed in a more general way, before the focus turns to
mycobacterial biofilms and their structure and components. This way the chapter pro-
gresses from the justification of the study towards the theory of the actual topic of this
thesis, which is mycobacterial biofilms.
2.1 Mycobacteria
Mycobacteria is a genus with varying natural hosts. The best known member of this
group of bacteria is Mycobacterium tuberculosis, which causes the tuberculosis disease.
The disease is usually caused by M. tuberculosis complex, which contains other mycobac-
teria as well. The mycobacteria associated with the M. tuberculosis complex besides the
obvious M. tuberculosis include Mycobacterium canettii, Mycobacterium africanum and
Mycobacterium bovis among many others [4]. The mycobacteria that are not part of the
M. tuberculosis complex are referred to as non-tuberculous mycobacteria (NTM). How-
ever, even the NTM group includes some significant human pathogens. Mycobacterium
leprae causes leprosy and Mycobacterium ulcerans causes Buruli ulcers [5]. M. ulcerans
infection occurs mainly on skin, like M. marinum infections, but M. ulcerans can also
infect bone.
In the environment non-tuberculous mycobacteria, including M. marinum, are often
found as heterospecies biofilms [6]. The growth rate of NTM varies greatly between
species. Mycobacterium marinum is a relatively slow-growing, even though it grows
faster than M. tuberculosis. Mycobacterium smegmatis and Mycobacterium fortuitum
are examples of fast-growing NTM [7]. There is a lot of variation between different
mycobacterial species and even strains. Therefore for example biocides should be tested
for each strain separately [7]. This variability between strains could partly explain the
persistence of M. tuberculosis and other mycobacterial infections.
2.2 Mycobacterium tuberculosis
Tuberculosis is one of the oldest known human diseases [8]. It can affect bone, the central
nervous system and many other organs, but it mainly manifests in the lungs. The infection
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begins when M. tuberculosis reaches the lung alveolar surfaces. The bone attacking form
causes deformities in the skeleton and these deformities have been discovered in 4 000
year old skeletons. It was common in ancient Egypt, but it has also been found in Neolithic
sites in Italy, Denmark and Middle Eastern countries, suggesting that tuberculosis was
infecting people around the world already 4 000 years ago [8].
The causative agent of the tuberculosis disease was identified by Koch in 1882 and it
was named a year later as Mycobacterium tuberculosis [9]. In 1920’s Calmette and Guerin
produced an attenuated vaccine from M. bovis strain, which would immunize the popula-
tion against tuberculosis. In 1940’s the antibiotic streptomycin was discovered by Schaltz
and Walksman, and this antibiotic was used to treat tuberculosis patients [8]. Later on
other antibiotics were also used in the treatment of tuberculosis. The current antibiotic
combination prescribed for tuberculosis typically consists of isoniazid, rifampicin, pyraz-
inamide and ethambutol [10]. Even though huge advances have been made, the number
of tuberculosis cases is still high, especially in the developing countries [8].
2.2.1 Infection
The progression of tuberculosis infection can be divided into four stages. Around 3 to
8 weeks after M. tuberculosis is deposited on the alveoli the bacteria spread to lymph
nodes. The lymph node infected by the bacteria forms the so called Ghon complex [8].
The Ghon complex usually resolves eventually, but it leaves signs of calcification and
fibrosis, which can be seen with x-Ray [11]. During the second stage of the infection the
bacteria is transported to other organs and to other parts of the lung. This stage often lasts
around 3 months [8]. The third stage usually lasts 3 to 7 months and can involve severe
chest pain caused by inflammation of the pleural surfaces. However, there can also be a
2 year gap between the second and the third stage. The last stage and the resolution of
the Ghon complex can occur after the infection started [8]. In most cases the tuberculosis
infection does not progress after the initial steps and no symptoms appear. This is called
latent infection. The latent infection can reactivate after years, decades or never.
As M. tuberculosis enters the alveolar passages the bacteria are first phagocytosed by
alveolar macrophages and dendritic cells [12]. The M. tuberculosis or its components
are recognized by several different host receptors including Toll-like receptors (TLR) and
C-type-lectins [12]. The phagocytosed bacteria are placed in an endocytic vacuole called
phagosome. As the M. tuberculosis enters the host, its metabolism changes. When grown
in vitro M. tuberculosis prefers carbohydrates as energy source but in vivo it uses fatty
acids as the preferred energy source [8].
In normal phagosome maturation cycle the phagosome would fuse with lysosome and
the bacteria would be destroyed by acid pH, reactive oxygen intermediates, lysosomal
enzymes and toxic peptides [8]. However, M. tuberculosis is able to survive within the
phagosome and to prevent the phagosome maturation and the fusion of the phagosome
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with the lysosome [13]. The proton ATPases are excluded from mycobacterial phago-
somes and this is believed to prevent their acidification [8]. The live phagocytosed M.
tuberculosis also prevents increases in Ca2+ levels, which are associated with the fusion
of phagosome and lysosome [14]. Several immune responses are also stimulated by Ca2+,
so the limited Ca2+ levels help M. tuberculosis to protect itself from the host’s immune re-
sponses [8]. The phagosomes containing M. tuberculosis express Rab5, which is a protein
associated with early endosomes. These phagosomes therefore do not recruit Rab7, which
is a protein associated with more mature endosomes [15]. However, it is not yet known
whether the lower Ca2+ levels and/or the Rab7 exclusion are required to stop phagosome
maturation or if they result from it [8]. By residing within the phagosome, the bacteria
are hidden from the CD4+T cells and as a possible result the expression of the major
histocompatibility complex class II (MHC-II) proteins is decreased, as well as the presen-
tation of MHC-II bacterial antigens [16]. A secreted or surface exposed M. tuberculosis
lipoprotein, sometimes referred to by its size as 19-kDa, is believed to interact with TLR2
when the bacteria enter the macrophages [8].
In the next steps of the M. tuberculosis infection the bacteria residing in the macro-
phages attract inactivated monocytes, lymphocytes and neutrophils. None of these are
able to kill the bacteria and clear the infection. Instead these cells are used to form a gran-
uloma and the bacteria are contained within it. Within the granulomas the bacteria spreads
from infected macrophages to uninfected macrophages [13]. The beginning of granuloma
formation correlates with rising bacterial count [17]. Mature established granulomas are
porous allowing entry of the bacteria to the already established granuloma [18]. Cellular
immunity helps to destroy the infected macrophages creating the caseous, necrotic center
of the granuloma [8]. Even though granulomas limit the growth of M. tuberculosis, it is
obvious that the mycobacterium has evolved to take advantage of them and use them as
a protection against the host immune system [13]. The M. tuberculosis bacteria residing
in the granuloma may enter dormancy and they can remain dormant for decades. The
bacteria are most likely dying and dividing at same rate so the bacterial count remains
constant. This is the basis of the latent M. tuberculosis infection, which is asymptomatic
and nontransmissible [8].
If the immunity of the host remains uncompromised, the infection may stop here and
the granulomas eventually heal so that only small fibrous and calcified lesions remain.
This is often referred to as cleared latent infection. However, if the host’s immune sys-
tem becomes compromised, the center of the granuloma may become liquefied serving
as a rich medium for the reviving bacteria. The revived M. tuberculosis can escape the
granuloma and spread within the lungs or to other organs resulting in an active infec-
tion [8]. Since the overall health affects the immune system, tuberculosis flourishes in
malnourished and overcrowded populations.
Extensive growth of M. tuberculosis in the lungs causes severe lung damage and even-
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tually leads to death by suffocation [8]. The amount of lung parenchymal cells, which are
involved in oxygen intake, is significantly reduced close to none, the bronchiolar passages
are blocked by granulomas and the rupture of liquefied granulomas releases blood to the
lung tissue, all of these leading to suffocation [8]. The tissue damage associated with M.
tuberculosis infection is mainly caused by inflammatory host responses. Proteases are
believed to be responsible for liquefication of granulomas and to cause the tissue damage.
The phagocytosis of M. tuberculosis can also lead to apoptosis of the macrophages, which
also may result as tissue damage. The tumor necrosis factor α (TNF-α) cytokine is a part
of the inflammatory response and necessary for infection control [8]. In mice it is required
for granuloma formation, but in large amounts it will cause severe lung inflammation and
early death. A clinical M. tuberculosis strain, CDC1551, was thought to have exception-
ally high virulence. Since virulence is defined by mortality and bacterial loads, the strain
did not have higher virulence than others. However, it induces significantly higher levels
of cytokines, including TNF-α, leading to a seemingly more virulent phenotype [8]. It
seems that in some cases the apoptosis of the macrophages is dependent on TNF-α and
that the more virulent M. tuberculosis strains induces lower levels of TNF-α, leading to
less apoptosis [8]. There are also other factors besides TNF-α that affect the progression
of the tuberculosis.
2.2.2 Virulence
There are several proteins believed to be linked to M. tuberculosis virulence and growth
within human host. One of them is HspX, which is a 16-kDa protein found in the M.
tuberculosis culture filtrate, but it is also recognized by sera of tuberculosis patients, sug-
gesting it is produced during infection in humans. The production of the protein is in-
duced under anoxic conditions and in human THP-1 macrophages. The protein might
have a chaperone-like function and it could be involved in latency control [8]. The pre-
viously mentioned 19-kDa protein is also recognized by sera of tuberculosis patients as
well as the T cells and it is believed to initiate a host signaling pathway by interaction
with TLR2. Several studies have been conducted regarding the 19-kDa protein. It seems
that the protein might induce different signaling pathways depending on the cell, which it
is interacting with [8].
ESAT-6 (6 kDa early secreted antigenic target) and CFP-10 (10 kDA culture filtrate
protein) are also M. tuberculosis culture filtrate proteins and recognized by sera of tuber-
culosis patients [8, 13, 19]. These proteins are expressed from the ESX-1 locus, which
is removed from the attenuated M. bovis strain (M. bovis BCG) used for M. tuberculosis
vaccination [19]. The two proteins are co-secreted with a third protein called EspA, which
lies outside of the ESX-1 locus [13]. A fourth protein, EspB, is secreted when CFP-10
is not present [20]. The ESAT-6 has been suggested to be a signal that induces secretion
of matrix metalloproteinase Mmp9 in epithelial cells. Mmp9 facilitates the recruitment
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of macrophages and therefore promotes the expansion of the granuloma [21]. A func-
tional ESX secretion system is required for phagosome maturation arrest [22] and the
phagosomal escape is also dependent on the ESX-1 secretion system [13]. The ESX-5
secretion system is required for secretion of proteins of proline-glutamic acid (PE) and
proline-proline-glutamic acid (PPE) families, but the functions of these families remain
partly unknown [23]. Some of the PE and PPE proteins are located on the cell surface and
some are known to interact with the host immune system.
Glutamine synthase is also found in M. tuberculosis culture filtrate, but this is believed
to be a result of cell leakage and lysis. Inhibition of this enzyme by L-methionine-SR-
sulfoximime (MSO) also inhibits M. tuberculosis growth both in vitro and in vivo, but the
inhibitor has no effect on nonpathogenic mycobacteria. In M. tuberculosis the glutamine
synthase is known to be involved in the synthesis of poly-L-glutamate-glutamine, which
is a cell wall component of pathogenic mycobacteria [8].
Not all virulence factors of M. tuberculosis are secreted. The cell surface of M. tu-
berculosis contains several proteins and other components that affect the virulence of the
bacterium [8]. One of these proteins is Erp. It is not found in non-pathogenic mycobac-
teria and a mutation in this gene leads to an attenuated infection in cultured macrophages
and animal models and also to higher susceptibility to detergents [8, 13]. The exact func-
tion of the protein is still unknown, but it is known to interact with two proteins located
on the cell membrane of M. tuberculosis. The other one of these proteins is not present in
NTM [24]. However, Erp can be found in other pathogenic mycobacteria as well. HbhA
is also a protein found on the cell surface of M. tuberculosis. It is a heparin binding
hemagglutin protein found in pathogenic mycobacteria. Mutants lacking HbhA interact
normally with macrophages, but they do not interact with pneumocytes [25]. It seems that
HbhA plays more important role in extrapulmonary tuberculosis.
Some M. tuberculosis cell wall lipids, like phthiocerol dimycocerosate, trehalose dimy-
colate and phenolic glycolipids, have been identified as important determinants of viru-
lence [13]. In cultured macrophages purified and cyclopropane modified trehalose dimy-
colate induces pulmonary granulomas and phenolic glycolipids inhibit the release of
proinflammatory cytokines [13]. Lipoarabinomannan is also an important virulence fac-
tor. It downregulates the host’s responses to M. tuberculosis infection in several ways [8].
Several of the cell wall lipids interact directly with the host immune system enabling the
M. tuberculosis to survive and replicate. Several enzymes have also been identified as
essential for M. tuberculosis virulence. Many of these are involved in the synthesis of ph-
thiocerol dimycocerosate or located near the gene cluster involved in the synthesis [8]. It
seems that phthiocerol dimycocerosate is an important factor in M. tuberculosis virulence
and mutations that disrupt or reduce its synthesis would result in attenuated infection phe-
notypes. Enzymes involved in production of other cell wall lipids have also been linked
to M. tuberculosis virulence [8]. At least some of these lipids are only present in the cell
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walls of pathogenic mycobacteria. The composition of mycobacterial cell wall will be
discussed later in greater detail.
2.2.3 Zebrafish as an infection model for tuberculosis
There are a few mammalian animal models developed for M. tuberculosis infection. Mice
form only poorly organized and non-caseating macrophage aggregates [26]. The best
resemblance with granuloma pathology of humans has been achieved in macaques and
macaques also have both the active and latent state of the disease [13]. However, the use
of macaques is quite unethical and also costly. Mice have also been used as a model of
M. marinum infections, but the bacterial count decreases over time and the granulomas re-
main non-caseating [13]. An interesting result found in mouse studies is that M. marinum
immunization offers protection against M. tuberculosis [27]. This is an interesting result,
since it could be a proof of close resemblance between the two bacteria. The resemblances
between M. tuberculosis and M. marinum will be discussed further later.
Zebrafish on the other hand develop a symptomatic wasting M. marinum infection with
caseating granulomas resembling the granulomas of active human tuberculosis [13]. The
granulomas in zebrafish are usually multi-centric and surrounded by a fibrous capsule
[28]. Another advantage with zebrafish as an infection model is the genetic variability,
which mimics the genetic variability in the human population. The genetic background
affects the individual’s ability to control and clear the infection and in heterogeneous
zebrafish population the effects of genetic variance can be studied [29]. Zebrafish are also
small, quite inexpensive and easy and fast to breed.
Zebrafish have both innate and adaptive immunity with conserved orthologues of key
human immune molecules [30]. The adaptive immunity develops later than the innate
immunity, like in mammals. T cells appear in the thymus 3 days after fertilization, but the
functional T cells exit the thymus only three weeks after fertilization [13]. This gives a
chance to study the effects of innate immunity alone by infecting the zebrafish only a few
days after the fertilization. Zebrafish larvae express a wide variety of toll-like receptors,
which generally play an important role in innate immunity, and some of these receptors
are induced during M. marinum infection [13]. Two types of genes, structurally related to
Ig-type receptors and C-type lectin receptors found in mammalian natural killer cells, are
expressed in zebrafish and these receptors are believed to contribute to the innate immu-
nity [31]. M. marinum is phagocytosed within 1 h after intravenous injection into 30 h old
zebrafish embryos. However, the embryonic macrophages are unable to eradicate the bac-
teria. The pro-inflammatory cytokines TNF and IL-1β are induced within first 24 h [32].
The infected macrophages aggregate within 4 days and form structures resembling gran-
ulomas [13]. The granuloma formation does not therefore require adaptive immunity
responses. However, the adaptive immunity response is required for proper control of the
infection, since the rag1 mutants are hypersusceptible to M. marinum infections [33]. The
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innate mechanisms seem to mainly modulate the inflammatory and bactericidal response
to infection [34].
M. marinum infection in zebrafish can either manifest as an acute infection or as
a chronic progressive disease. The acute infection leads rapidly to lethal inflamma-
tion, but the chronic diseases progresses slower and usually leads eventually to abdom-
inal swelling, uncoordinated swimming, weight loss, hemorrhages and skin ulcerations
[35, 36]. Before visible symptoms in zebrafish granulomas develop in organs, such as
liver, spleen, kidney, pancreas and intestines [29]. The organ block can be collected and
the M. marinum load determined with quantitative PCR (qPCR). Zebrafish can also be
used to mimic a latent M. tuberculosis infection. This model can be achieved with low
bacterial loads in infection [28]. After several weeks the bacterial counts become stable
and the number of granulomas remains constant. This latency relies on rag1-mediated
adaptive immunity. The bacteria residing in granulomas becomes dormant. The infection
can be reactivated with immunosuppression induced by gamma irradiation [28].
Embryonic zebrafish are transparent, which enables real time monitoring of M. mar-
inum infection in vivo, especially when fluorescent bacteria are used. With the use of
low concentrations of 1-phenyl-2-thiourea the zebrafish larvae will also remain transpar-
ent [37]. Modified antisense oligonucleotides, morpholinos, designed to inhibit mRNA
translation or splicing, can be used for reversed genetics in in zebrafish embryos and lar-
vae [13]. This enables studies with altered phenotypes. Retroviral insertions can also be
used to identify germline mutants in specific genes [13]. Similar effects to the knockdown
of CCL2-CCR2 signaling, which is associated with macrophages recruitment, can be
achieved in zebrafish with mutations of cxcr3.2, which is a homologue of human CXCR3
receptor [38].
2.3 Mycobacterium marinum
Mycobacterium marinum is an NTM found in both fresh and saltwater. It is a slow grow-
ing mycobacterium, but its generation time is significantly shorter than the generation
time of M. tuberculosis [13]. The optimal growth temperature for M. marinum is be-
low 30 ◦C. M. marinum was first discovered in 1926 in an aquarium from dead saltwater
fish [39]. It infects mainly fish, but can also cause a skin infection in humans. The first
identified human M. marinum infection was reported in Sweden in 1951 by Norden and
Linell [39]. In fish the infection resembles the human tuberculosis infection. For the
infection to occur in humans, M. marinum requires an access to the bloodstream via in-
jured skin. In humans the symptoms are milder and occur usually only on the surface
of the skin in the outer limbs. This is most likely a result of the lower optimal growth
temperature, since hands and feet tend to have lower temperature than the core body.
The M. marinum infection in humans is often referred to as fish tank or swimming pool
granuloma. In immunocompromised individuals the disease can, however, resemble more
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closely M. tuberculosis infection. The M. marinum infection results in fish and humans as
similar granulomas as associated with M. tuberculosis infections. Since M. marinum and
M. tuberculosis are closely related M. marinum along with other NTM has been used to
study mycobacterial infection mechanisms, which could be shared with M. tuberculosis.
As stated in the previous section, the zebrafish has been used as a model organism in M.
marinum studies.
2.3.1 Infection
It is not yet completely understood how M. marinum enters its natural host, fish, and be-
gins the infection. The two main ideas at the moment seem to be via the gastrointestinal
system or by the gills. However, by injecting M. marinum to the caudal vein of zebrafish
embryos, the early events of M. marinum infection in zebrafish can be studied [40]. The
injected bacteria were immediately phagocytosed by blood macrophages. The bacteria are
able to transfer between two macrophages and the infected macrophages can be phagocy-
tosed by uninfected ones, which will then become infected [40]. Within 1 day the infected
macrophages had been spread to different tissues. In zebrafish embryos the bacteria was
phagocytosed only by macrophages, but with adaptive immune system, other cells are
likely also involved in the establishment of the infection.
3 days after the injection, the infected macrophages located in the tissues of the embryo
start to form aggregates, which would eventually turn into granulomas. The aggregated
cells are squeezed together tightly and new cells are added to the aggregates [40]. The
aggregates in zebrafish embryos consist solely of macrophages and the membranes of
these cells were tightly packed next to one another or the cell boundaries were indistinct.
The granulomas contain also uninfected cells. The bacteria resides both intracellularly
in the aggregates and extracellularly in the necrotic center [40]. The number of bacteria
residing in a necrotic centers varies greatly between granulomas. High initial bacterial
loads killed the embryos within 6 to 9 days. Heat-killed M. marinum is phagocytosed by
macrophages in similar manner, but the bacteria is degraded within 2 days [40]. Differ-
ent M. marinum genes are activated upon phagocytosis and in aggregated macrophages
in adult zebrafish. The same genes were also activated in the zebrafish embryos in cor-
responding situations [40]. This shows that the macrophage aggregates in the embryos
resemble the granulomas found in adult zebrafish.
In very low bacterial concentrations of M. marinum containing phthiocerol dimy-
cocerosates can use the CCL2-CCR2 chemokine signaling axis to recruit permissive
macrophages in a phenolic glycolipid dependent way [41]. CCR2 is required to mobi-
lize the monocytes from the bone marrow and to move them to the inflammation site [42]
and at least in murine models CCR2 deficiency impairs the host defense [29]. The CCL2
is generally considered as an inflammatory chemokine, but it can also change the polariza-
tion of macrophages closer to an anti-inflammatory phenotype [43]. The high expression
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of CCL2 also seems to correlate with susceptibility to tuberculosis [44].
2.3.2 Virulence
The ESX system is important for M. marinum virulence. The ESAT-6 and CFP-10 pro-
teins are co-secreted with EspB [22]. The function of the ESAT-6 is believed to be similar
in both M. marinum and M. tuberculosis, so it is believed to induce a signal that results
in expansion of granulomas by recruitment of macrophages [21]. The M. marinum esx-1
mutants are phagocytosed normally and replicate within the macrophage normally, but
they fail to form granulomas [17]. Mutations in the M. marinum ESX-1 secretion system
also prevent phagosomal escape and the resulting cytosolic actin polymerization and cell
to cell spread [13]. Phagosome maturation arrest also requires a functional ESX secretion
system [22]. The ESX-1 secretion system seems to promote macrophage aggregates and
therefore the granuloma formation.
The ESX-5 secretion system is required for secretion of proteins of proline-glutamic
acid (PE) and proline-proline-glutamic acid (PPE) families, but the functions of these
families remain partly unknown [23]. Some of the PE and PPE proteins are located on the
cell surface of M. marinum and they are known to interact with the host immune system.
The ESX-5 mutants of M. marinum cause different infection phenotypes in embryos and
in adult zebrafish. In embryos the infection phenotype is a bit attenuated, but in adults it
is hypervirulent [23]. The difference could be caused by the adaptive immunity, which
the embryos lack, however, the ESX-5 mutants grew better even in rag1 mutant adult
zebrafish, suggesting that the difference in infection phenotypes lies elsewhere. It seems
that M. marinum requires the ESX-5 secretion system for establishment of persistent in-
fection [29]. The same study [23] also showed that it is useful and occasionally even
necessary to use both embryos and adults before proper conclusions can be made.
Mutation in the erp gene causes an attenuated infection in cultured macrophages and
animal models and also higher susceptibility to rifampicin [13]. These mutants seemed
to be phagocytosed normally, but they are unable to survive within the macrophages [45].
A depletion of macrophages normalizes the infection phenotype, suggesting that the se-
creted surface protein erp encodes only interacts with macrophages [32]. On the other
hand, a mycobacterial infection lacking macrophages can hardly be called normal, since
macrophages seem to be a vital part of the infection mechanism. Another gene affecting
the infection phenotype is iipA. A mutation in the iipA gene affects the cell wall structure
of M. marinum leading to higher antibiotic susceptibility [13]. The gene contains highly
conserved domains that are believed to mediate peptidoglycanase activity. These mutants
form deficient biofilms and their invasion and intracellular survival are defective, leading
to an attenuated infection [13].
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2.4 Comparison between M. marinum and M. tuberculosis
M. tuberculosis and M. marinum are closely related mycobacteria that infect macrophages
and cause a chronic and systemic disease [13]. However, their natural hosts are very dif-
ferent. The natural host of M. tuberculosis is human, but for M. marinum it is ectotherms
like fish and frogs [13]. The optimal growth temperatures are also different, correlating
with the natural hosts. The optimal growth temperature for M. marinum is below 30 ◦C
and for M. tuberculosis it is around 37 ◦C.
The generation time during logarithmic growth of M. marinum is 4 h, which is signifi-
cantly shorter than the generation time of over 20 h of M. tuberculosis [13]. M. marinum
forms visible colonies on agar in a week, but M. tuberculosis requires three weeks [36].
Despite the differences in natural hosts and generation times, the genetic programs are
well conserved between the two bacteria and therefore they have many shared determi-
nants of virulence [13]. The faster growth combined with lesser threat to humans make
M. marinum an interesting model organism for M. tuberculosis studies.
2.4.1 Genetics
The M. tuberculosis genome is only two thirds of the M. marinum genome, which is
6.6 Mbp and it is possible that most of the difference in the genome sizes is due to a
loss of genetic material in M. tuberculosis [13]. As M. tuberculosis specialized to sur-
vive mainly intracellularly, it may have lost genes that are important for extracellular
survival. An example is the light induced beta-carotene production in M. marinum, which
turns the bacterial cultures yellow. It protects the bacteria from photo-oxidation dam-
age [46]. The photochromogenicity of M. marinum has also been linked to intracellu-
lar survival, since disruption of a region between two genes, which have homologues in
M. tuberculosis increases the susceptibility to singlet oxygen and decreases the survival
in macrophages [47].
Besides losses in the M. tuberculosis genome, M. marinum has also acquired new loci
via gene duplication and lateral gene transfer after the divergence from M. tuberculo-
sis [48]. 14 % of the M. tuberculosis genome is not shared with M. marinum [48], but this
part is hypothesized to be mostly related to host transmission and organ specificity instead
of central pathogenesis mechanisms [13]. The identity between the M. marinum genome
with the orthologous regions of the M. tuberculosis genome is 85 % and the coding se-
quence amino acid identity is also around 85 % between orthologues [48]. M. marinum
and M. tuberculosis have orthologous virulence determinants and the M. tuberculosis or-
thologues are able to compliment the M. marinum virulence determinants, suggesting a
conserved function [13].
An example of the shared virulence determinants are ESAT-6 and CFP-10, which are
secreted from the ESX locus. These two proteins are secreted virulence determinants
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found in M. marinum and M. tuberculosis. In both bacteria they are co-secreted with
a third protein, which is different between the two bacterial species. In both bacte-
ria the ESX secretion system is required for phagosome maturation arrest and phago-
somal escape. The conserved virulence determinants and similarities between the genetic
programs of intracellular growth and host survival suggest that the common ancestor of
M. marinum and M. tuberculosis was able to colonize in vertebrates with at least some
kind of primitive adaptive immune system [13].
2.4.2 Granulomas
In M. tuberculosis infection, as well as in M. marinum infection, the bacteria are phagocy-
tosed by host macrophages, but this does not actually help to eradicate the infection [13].
Both bacteria are able to survive and even replicate within the macrophages [49]. In
fact the phagocytosis is actually part of the survival plan of the bacteria. Mycobacte-
ria use the lipids of their outer cell wall to manipulate the macrophage [36]. The in-
fected macrophages migrate into tissues and aggregate into complex granulomas [13].
The structures of the granulomas as well as their assembling mechanisms are similar in
both bacteria. The cells are tightly packed and the boundaries between cells can be come
indistinguishable [40]. The acellular necrotic core is called caseum. The mycobacteria re-
side within the caseum extracellularly [13] or inside the infected macrophages [40]. Even
though granulomas limit the growth of mycobacteria, it is obvious that the pathogenic my-
cobacteria have evolved to take advantage of them and use them as a protection against the
host immune system [13]. M. tuberculosis can persist inside granulomas for decades as a
latent infection [50]. When the granuloma integrity is lost, the latent infection becomes
active and the disease can be transmitted further [29].
The phagocytosis induces specific gene expression patterns in both M. marinum and
M. tuberculosis. When these patterns were studied in M. marinum, most of the identi-
fied genes had orthologues in M. tuberculosis. However, the genes were constitutively
expressed in vivo in M. tuberculosis undoubtedly due to the intracellular survival tac-
tic, although the pathogenesis mechanisms may also affect [13]. As M. marinum is able
to survive both intracellularly and in the environment, the transitions require changes in
gene expression. These two alternating states partly explain the larger genome of M. mar-
inum. Since the niche of M. tuberculosis is restricted to host, there is less need for gene
regulation [13].
M. marinum and M. tuberculosis, like many other pathogenic mycobacteria, arrest the
phagosome maturation before the phagolysosome fusion [13]. It is only live M. marinum,
not dead, that prevents the fusion of macrophage and lysosome [36]. M. marinum local-
ize themselves to non-acidified phagosomes excluding the vacuolar proton ATPase [13].
This has been hypothesized to act as a protection against phagolysosome mediated killing.
It might also offer M. marinum a chance to alter the antigen presentation and therefore
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the adaptive immune response of the host [51]. M. marinum is also able to escape from
phagosomes to cytosol and develop an actin-based motility [52]. This escape has also
been suggested to occur in M. tuberculosis infections but the results are considered as
controversial [13]. It is possible that the phagosome escape of M. tuberculosis is un-
der tighter regulation than in M. marinum and therefore it has not been documented as
well [36]. However, M. tuberculosis does not have the actin based motility of M. mar-
inum or other means to propel itself outside host cells. The actin based motility of M.
marinum is believed to be used in the initial stages of infection and it has not been ob-
served in other mycobacteria, not even in M. ulcerans, which is the closest relative to M.
marinum [36].
The dermal M. tuberculosis granulomas and the M. marinum granulomas are usually
indistinguishable in humans, since they both have a lymphocytic cuff surrounding epithe-
lioid cells and the necrotic core in the center [13]. The M. marinum induced granulomas in
fish have very few lymphocytes, but these lymphocytes are important in restriction of the
bacterial growth [13]. The histopathologies of mature granulomas have more variation
between different hosts than between M. marinum and M. tuberculosis infections [13].
The M. tuberculosis infection in humans resembles the M. marinum infection in zebrafish
more than the M. tuberculosis infection in mice. It’s an interesting notion, since mycobac-
terial infections use the host immune system to their advantage and therefore the immune
system has also a great impact on the infection.
2.5 Biofilms
All bacteria, including mycobacteria, typically form biofilm [6]. These biofilms consist
of bacteria and extracellular matrix (ECM) produced by the bacteria. The biofilms are
either attached to a biotic or abiotic surface or suspended as flocks [7, 53]. Biofilms
are practically present everywhere. Currently one of the most harmful ones, possible
excluding the infectious biofilms within human body, are the biofilms present on medical
equipment. Biofilms can also be used to our advantage. For example in water treatment
plants biological water treatment is usually based on biofilms, because bacteria residing
in biofilms are more resistant than planktonic bacteria, which would just be washed away
with the treated water.
Biofilms offer bacteria several advantages and therefore biofilms have most likely
evolved as a survival tactic. One of the advantages is resistance to environmental threats.
These threats include antibiotics, biocides and other sterilization agents. For example
biofilms of NTM are highly tolerant to chlorine [6]. The biofilms attached to the surface
are not washed away as easily as planktonic bacteria. Biofilms also protect the bacteria
from phagocytosis and other immune responses, which makes biofilm associated infec-
tions more persistent and less responsive to antibiotics. The bacteria residing in biofilms
are dispersed as flocks and therefore they are more potent to spread infections. Even
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Figure 2.1: The steps of biofilm formation. The steps have been numbered and the first one is
attachment of the bacterium to the surface. The second step is bacterial division and formation of
the extracellular matrix and the third one is dispersal of the bacteria from the mature biofilm as
flocks.
though biofilms protect the bacteria from host immunity and enable more efficient spread-
ing of the infection, they are not a direct sign of pathogenesis. Many non-pathogenic
bacteria, too, form biofilms [53].
The formation of biofilm is a genetically controlled process with several steps [6].
These steps are illustrated in figure 2.1. The biofilm formation begins typically by attach-
ment to the surface and this attachment is usually mediated by filaments, which extend
from the bacteria [54]. The attachment is followed by bacterial division and the synthesis
of the ECM. Once the biofilm is mature, the bacteria can disperse from it as small flocks
and form biofilms at new locations [6].
The biofilm forming bacteria usually grow in a sigmoidal fashion [7]. It is reasonable to
assume that at first bacteria form the biofilm to protect themselves and only then they start
to divide. After the stable biofilm has been formed, the bacteria most likely concentrate
their resources on biofilm formation and therefore the bacteria are metabolically active
but not actively dividing. M. tuberculosis biofilms are unaffected by attacks against cell
wall biosynthesis, which could be a sign of reduced cell division [55].
Biofilms protect the bacteria from environmental conditions and antimicrobials. The
bacteria living in the center of the biofilm do still require nutrients and oxygen. Therefore
there are water channels in the biofilm, which are used to transport molecules in and out
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Figure 2.2: A wild-type M. marinum pellicle. In this culture the pellicle at the air-liquid interphase
is significantly larger than the pellet found at the bottom.
of the biofilm [7, 56].
Biofilms contain several microenvironments. The growth conditions are naturally very
different deep inside the biofilm compared to the outer surface of it. Bacteria adapt to
these microenvironments both physiologically and metabolically and therefore the bacte-
ria within the same biofilm are phenotypically heterogeneous, even though they have the
same genotype [57]. The heterogenicity is an advantage for the bacteria, possibly offer-
ing quicker responses to sudden conditional changes. The different microenvironments
also affect the cell length, which has been linked to phenotypic drug tolerance [6]. Im-
paired biofilms of mixed M. tuberculosis mutants are more susceptible to antibiotics than
the wild-type biofilms [6], making the different phenotypes more relevant than different
genotypes. Also in biofilm the bacteria can work together by dividing the production
of the ECM molecules. This would require quorum sensing. Some research about quo-
rum sensing and its link to biofilms has been done, but several unanswered questions still
remain [58].
2.5.1 Mycobacterial biofilms
The mycobacteria have a strong tendency to form biofilms in liquid cultures [6]. The
mycobacterial biofilms are usually attached to the bottom and to the sides of the culture
container. The biofilms attached to the bottom are generally referred to as a pellet and
the biofilm that forms in the air-liquid interphase is called pellicle. The pellicle is usually
attached to sides of the container. Figure 2.2 shows a large M. marinum pellicle at the air-
liquid interphase and a relatively small pellet at the bottom. The attachment of the pellicle
to the sides of the container can also be seen clearly in the picture. Detergents, such as
Tween R©80, can be used to reduce the biofilm formation and to grow more dispersed
cultures [6]. If the bacterial culture requires dilution before use, which would be the case,
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if the bacteria would be used for infection experiment, the dispersed cultures result in
more accurate dilution series.
The mycobacterial biofilms contain several different lipids. These lipids have been
suggested to form a hydrophobic film between the bacteria and the hydrophilic agar sur-
face [59]. This would reduce the interaction between bacteria and the agar and enable
the sliding motility of the bacteria. The interaction between two hydrophilic surfaces is
stronger and therefore the sliding would require more energy, since breaking the inter-
action between the two surfaces would require more energy. The lipids also facilitate
in attachment since they make the outer surface of the bacteria more hydrophobic and
therefore allow the attachment to the hydrophobic surfaces, like PVC [60].
The morphologies of biofilms vary between species. The fast-growing Mycobac-
terium fortuitum aggregates as heterogeneous filaments, where extracellular polymeric
substances are clearly visible [7]. M. marinum on the other hand forms more typical mi-
crocolonies, with individual bacteria and extracellular polymeric substances less promi-
nent and visible [7].
There are certain conditions that promote the formation of biofilm. Incubation of My-
cobacterium avium ssp. hominissuis in subinhibitory concentrations of streptomycin and
tetracycline induces the biofilm formation [61]. It is reasonable that low concentrations of
antibiotics would increase the biofilm formation, since the biofilm can be used to protect
the bacteria. Also the biofilm formation in M. avium seems to be dependent on Ca2+,
Mg2+ or Zn2+ ions, but the concentrations of the ions do not affect the biofilm formation
significantly, only their presence [59]. 2 % concentration of peptone and glucose also
induces the biofilm formation but humic acid was partially inhibiting [59].
In M. avium strains biofilm formation is more efficient in water than in 7H9 broth,
which is a commonly used mycobacterial medium [59]. Also in M. tuberculosis cultures
low nutrient and oxygen concentrations induce formation of non-replicating but viable
and drug tolerant bacteria [6]. The non-replicating bacteria are most likely actively form-
ing biofilm. The scarce nutrients may be concentrated into the biofilm and utilized by the
bacteria. Also a liquid media lacking salts may cause the cells to explode but inside the
biofilm the environment can be more concentrated, preventing the leakage of molecules
from the cell to the medium.
Biofilms have also direct effect on the virulence of mycobacteria. Biofilm defective
M. avium mutants are unable to colonize and translocate through bronchial epithelial cells
resulting in an attenuated infection [59]. Also the ECM of M. ulcerans biofilm contains
vast amounts of mycolactone, which is an extracellular toxin and the major virulence
factor of M. ulcerans, rendering the sterilized biofilm toxic as well [62]. UV-sterilized
biofilm of M. avium subsp. hominissuis stimulates the macrophages in a same way as
the non-sterilized biofilms did [63]. It seems that a component of the M. avium subsp.
hominissuis biofilm matrix induces the cell death of the macrophages instead of live bac-
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Figure 2.3: A simplified model of the structure of a typical mycobacterial biofilm. The cell is
surrounded by lipid envelope, and the envelope is surrounded by the extracellular matrix (ECM).
The ECM separates the bacteria from the environment.
teria.
Most of the mycobacteria form structures called cords, when they grow extracellularly
[13, 64]. In cords the bacteria are aligned parallel to each other along the long axis of the
cord forming string-like structures [65]. These were originally linked to virulence, since
in M. tuberculosis only virulent strains form cording structures [13]. However, they were
later found from non-pathogenic mycobacteria as well [64]. There seems to be a link
between cording structures and virulence in M. marinum as well [13]. M. marinum kasB
mutants, which will be discussed in more detail later, have defects in cord formation and
cause an attenuated infection in zebrafish [66].
With mycobacterial biofilms it must be taken into consideration that the differences
between in vitro and in vivo biofilms can be massive. As an example, it was determined
that mag5 gene, which is an M. marinum virulence determinant, was expressed at a low
level in cultured macrophages, but strongly activated in zebrafish embryos [40]. It seems
that the microenvironments within macrophages in vivo have a lot more variation than can
be simulated in vitro.
A simplified structure of an in vitro mycobacterial biofilm is shown in figure 2.3. The
mycobacterium is surrounded by lipid envelope, which is sometimes referred to as cell
envelope as well. Outside the lipid envelope is the extracellular matrix of the biofilm. The
lipid envelope is sometimes considered as part of the cell wall or as part of the extracellular
matrix. It appears to be somewhat difficult to point out in which parts of this biofilm
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structure certain molecules are found. The cell wall, lipid envelope and the extracellular
matrix will be discussed further in following sections.
Many of the biofilm characteristics are shared among different mycobacteria, possi-
bly partly due to the similar cell wall structure. The biofilms of M. marinum have been
studied surprisingly little, even though M. marinum is the one of the closest relatives of
M. tuberculosis. Also the availability of in vivo models for M. marinum studies make it
an interesting research topic.
2.5.2 Mycobacterial cell wall and the lipid envelope
Mycobacteria are classified as gram-positive, even though their cell wall contains some
characteristic of the cell walls of gram-negative bacteria as well [67]. The structure of the
mycobacterial cell wall is quite unique and a feature that can be used to set the mycobac-
teria apart from other bacteria. The mycobacterial cell wall contains an outer permeability
barrier, which acts like an outer membrane, but is not really one [67].
The core structure of the cell wall consists of mycolyl-arabinogalactan-peptidoglycan
molecules and it was discovered already back in 1982 by Minnikin [67]. The parts of the
molecule, mycolic acid, arabinogalactan and peptidoglycan, are covalently linked to one
another [68]. Mycolic acids are bound to the arabinogalactan polysaccharide layer [60].
These mycolic acids are largely responsible for the antimicrobial protection [54].
The mycobacterial cell wall is surrounded by an envelope consisting of various lipids.
This envelope is sometimes referred to as part of the cell wall and sometimes it is thought
to be part of the biofilm. This outer layer of the cell wall, or envelope, consists of sol-
vent extractable lipids that intercalate with mycolic acids [68]. The structure of these
lipids varies between mycobacterial species. The glycolipids found in mycobacterial en-
velopes include glycopeptidolipids, lipoarabinomannan, lipomannan, phthiocerol dimy-
cocerosates, lipooligosaccharides, phenolic glycolipids and trehalose dimycolate [68].
In mycobacterial biofilms the correct cell wall structure is the basis of biofilm forma-
tion and therefore cell wall biosynthesis is very important for proper biofilm formation [5].
Defects in cell wall structures cause defects in biofilms. Some of the molecules found in
the mycobacterial cell wall are also secreted into the biofilm matrix. Several components
of the cell wall have also been linked directly to virulence.
As said, different mycobacteria have different lipids in the envelope. Glycopepti-
dolipids, which have been studied a lot, are found in M. smegmatis and M. avium, but
not in M. tuberculosis or M. marinum [59, 69]. In M. tuberculosis the envelope contains
phenolic glycolipids, phthiocerol dimycocerosate and lipooligosaccharides [69].
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Lipoarabinomannan
Lipoarabinomannan is a glycophospholipid that is anchored to the mycobacterial plasma
membrane, but also found in the upper layers of mycobacterial cell envelope [70]. All
mycobacteria produce lipoarabinomannan, since it is a part of the characteristic my-
cobacterial cell wall structure [71]. Lipoarabinomannan binds to cell surface receptors
of macrophages and dendritic cells inducing various immunomodulatory effects, down-
regulating the cell mediated immunity and aiding the invasion of the host cell [72].
Lipoarabinomannan is known to insert itself into the endomembranes and traffic within
the infected cells. It is also known to inhibit the phagosomal maturation [70]. The
lipoarabinomannan of M. tuberculosis is capped with mannose and it prevents the in-
crease in Ca2+ levels during M. tuberculosis infection. The lipoarabinomannan found
in non-pathogenic mycobacteria lacks the mannose cap and cannot cause this inhibition,
suggesting that the mannose cap is essential for the inhibition [70]. Mannose also acts as
a lipid anchor of lipomannan and lipoarabinomannan [73].
Another glycophospholipid, phosphatidylinositol mannoside, also plays a role in M. tu-
berculosis infection. Phosphatidylinositol mannoside promotes the fusion of early endo-
somal compartments while lipoarabinomannan prevents the attachment of late endosomal
and lysosomal factors [70]. Together these effects prevent the phagosome maturation and
fusion with the lysosome while helping the fusion of mycobacteria containing phago-
somes.
Lipooligosaccharides
The lipooligosaccharides in M. marinum are required for sliding motility and entry to
macrophages [68]. Defects in lipooligosaccharide biosynthesis also cause defects in
biofilm formation [68]. The inefficient phagocytosis of the mutants suggests that the
lipooligosaccharides interact directly with the host macrophages [68].
Lipooligosaccharides were originally found in M. kansasii [74], but they are also
present in some M. tuberculosis and M. marinum strains [68]. In M. kansasii lipooligosac-
charides are only found in smooth strains, but similar correlation between colony mor-
phology and lipooligosaccharides has not been found in M. tuberculosis [75, 76]. The M.
kansasii strains completely lacking the lipooligosaccharides cause chronic systemic infec-
tions in mice, but the smooth variants, which produce lipooligosaccharides, are cleared
quickly from the animal’s organs and fail to cause a proper infection [68]. It was there-
fore suggested that lipooligosaccharides might be an avirulence factor that somehow over-
comes the effects of the other cell wall lipids. Most clinical isolates of M. tuberculosis do
not contain lipooligosaccharides, supporting the previous idea [68]. However, in M. mar-
inum lipooligosaccharides are required for phagocytosis, which invalidates the idea of
lipooligosaccharides as an avirulence factor.
2. Theoretical background 20
In M. kansasii there are eight closely related lipooligosaccharides. They all have the
same tetraglucose structure: D-Glcp-(β1 → 3)-D-Glcp-(β1 → 4)-D-Glcp-(α1 → 1α)-
D-Glcp. This structure contains the trehalose moiety at the end [68]. All M. kansasii
lipo-oligoaccharides also contain a 3-O-methylrhamnose and varying amounts of xylose,
fucose and N-acylkansosamine, which is a novel N-acyl amino sugar. In other mycobac-
teria there are significant variations in both core sugar groups and in terminal sugar moi-
eties [68]. Since lipooligosaccharides are located on the surface and there are signifi-
cant variations in the terminal immunodominant monosaccharide between mycobacterial
species, they can be used to serotype the particular mycobacterial species [68].
M. marinum produces four types of lipooligosaccharides, which are named LOS-I,
LOS-II, LOS-III and LOS-IV. The core sugar groups are similar to M. kansasii, but the
terminal sugar moieties are unique to allow the serotyping [77]. Disruption of the losA
gene, which encodes a glycosyltransferase, prevents the formation of LOS-IV and causes
accumulation of LOS-III, so the losA gene is part of the LOS-IV biosynthesis [77]. Also
the lack of LOS-IV causes defects in macrophage entry [68]. Other genes related to the
lipooligosaccharide synthesis in M. marinum have been identified. Disruption in gene
MM2309 prevents the synthesis of LOS-II and disruption in gene MM2332 causes an
intermediate of LOS-I and LOS-II to accumulate [68]. This intermediate lacks an uniden-
tified sugar residue, suggesting that MM2332 encodes an enzyme involved in the syn-
thesis of the said sugar molecule or an enzyme responsible of the transfer of the sugar
molecule [68]. These defects can be rescued with corresponding genes of the wild type
M. marinum. Both of these mutations also cause altered colony morphology [68]. The
gene MM2309 encodes for UDP-glucose dehydrogenase, which converts UDP-D-glucose
to UDP-D-glucuronate in the UDP-D-xylose synthesis. The MM2310 gene, which is
downstream from the MM2309 gene most likely encodes UDP-glucuronate decarboxy-
lase, which catalyzes the second step of UDP-D-xylose synthesis [68].
The genes MM2309, MM2310 and MM2332 are all found in the same genetic lo-
cus [68]. This locus containing genes MM2309 through MM2341 is considered as the
lipooligosaccharide biosynthetic cluster. Other cell wall lipid biosynthesis genes are of-
ten organized in a similar fashion [68]. The genes MM2309 through MM2318 are in
the same orientation, but only genes MM2309 through MM2312 were found to be tran-
scribed together. The polycistronic operon containing these genes does not contain gene
MM2313 [68].
Phenolic glycolipids
Phenolic glycolipids have a long-chain fatty acid backbone consisting of p-glycosylated
phenylglycols that have been diesterified with di- to tetramethyl branched acyl chains [78].
They are produced only by pathogenic mycobacteria and only by some clinical isolates
of M. tuberculosis [78]. However, the M. tuberculosis strains producing phenolic gly-
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copeptidolipids are hypervirulent and they inhibit the release of proinflammatory effector
molecules [79]. It seems that the production of phenolic glycolipids correlates with the
hypervirulence but does not cause it. M. marinum mutants lacking phenolic glycolipids
have defects in cording and these mutants also have attenuated infection phenotypes in
zebrafish [78]. The phenolic glycolipids are believed to inhibit the release of proinflam-
matory cytokines [13]. In M. leprae they are involved in attachment and entry to the
Schwann cells [78].
The genes involved in the production of phenolphthiocerols, which is the backbone
of phenolic glycolipids, come from the same gene cluster. This same gene cluster also
produces the enzymes required for synthesis of phthiocerol dimycocerosate [78]. To
produce phenolphthiocerol in M. marinum p-hydroxybenzoic acid is first converted to
p-hydroxyphenylalkanoic acid, which is then converted to phenolphthiocerol. The my-
cocerosates are synthesized by a specific polyketide synthase, Mas or FadD28. The phe-
nolphthiocerols are then diesterified with mycocerosates by PapA5 enzyme. The last step
of production of phenolic glycolipids is the glycosylation [78]. The structures of phenolic
glycolipids are similar in M. marinum and M. tuberculosis, but the stereochemistry of their
mycocerosates is different. In M. marinum the mycocerosates are dextrorotatory, while
in M. tuberculosis they are levorotatory [78]. It would be interesting to know whether
the M. marinum Mas enzyme could be replaced with the corresponding enzyme from M.
tuberculosis and if it could, how the different stereochemistry would affect the structure
of the cell envelope or the biofilm.
Phthiocerol dimycocerosate
Phthiocerol dimycocerosates have been identified in several pathogenic mycobacteria,
including M. marinum and M. tuberculosis [78]. In M. tuberculosis the phthiocerol dimy-
cocerosates prevent the phagosomal maturation. The M. marinum and M. tuberculosis
strains with impaired phthiocerol dimycocerosate production or localization cause atten-
uated infections in animal models [8, 78]. In M. marinum the lack of phthiocerol dimy-
cocerosate causes visible defects in cording and reduces virulence [78]. In both M. tu-
berculosis and M. marinum lacking phthiocerol dimycocerosates or phenolic glycolipids,
the cell wall becomes more permeable and the bacteria are more susceptible to antibi-
otics [78]. Phthiocerol dimycocerosates are therefore important for both virulence and
for the cell wall structure, and therefore for the biofilm as well.
Phthiocerol dimycocerosate backbone consists of 3-methoxy (or 3-keto, 3-hydroxy),
4-methyl, 9,11-dihydroxy glycols, which are then diesterified similarly as phenolic gly-
colipids. In M. marinum many of the genes used for synthesis of are similar or same
as the ones used in the phenolic glycolipid synthesis [78]. All the genes come from the
same gene cluster, both the genes for synthesis of phthiocerol dimycocerosates and for the
synthesis of phenolic glycolipids. The mycocerosate is produced by the same enzymes,
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Mas or FadD28. Also the enzyme that catalyzes the diesterification of phthiocerols and
mycocerosates is the same one that catalyzes the diesterification of phenolphthiocerols
and mycocerosates [78].
The stereochemistry of mycocerosates affects also phthiocerol dimycocerosates. It
seems possible that the enzymes could be substituted with each other, but it would cer-
tainly affect the structure of the cell envelope, since it would be more than one kind of
lipids that would be affected. Since the integrity of the cell wall is essential for the proper
biofilm formation, this wide changes in the structure of the envelope would certainly af-
fect the biofilm formation.
2.5.3 Extracellular matrix of mycobacterial biofilms
The extracellular matrix (ECM) in other biofilm forming bacteria consists most often of
exopolysaccharides, proteins and DNA [54]. Exopolysaccharides are one of the most
predominant components of biofilms in Gram-positive and Gram-negative bacteria [80].
Mycobacterial biofilms are exceptional, since mycobacteria do not secrete polysaccha-
rides and it seems that they are not even able to produce them [54]. Another important
component of the ECM in many bacteria, including mycobacteria, is extracellular DNA
(eDNA). The ECM also contains some proteins, which are related especially to the cell to
cell and cell to surface attachment [6]. The composition of the ECM varies a lot between
different species and even strains. The ECM holds the bacteria residing in the biofilm
together [6].
The ECM of mycobacterial biofilms is very lipid rich. Some of the lipids present in the
cell envelope are also secreted to the ECM and sometimes the cell envelope is considered
as part of the ECM. The lipids facilitate the attachment of the biofilm to surfaces by
creating a hydrophobic outer surface [60]. Since mycolic acids seem to be essential at
least for M. smegmatis biofilms, they will be discussed in more detail in the following
section [5]. After that extracellular DNA will be discussed as a component of the ECM,
since it too seems to be important for mycobacterial biofilms.
Mycolic acids
Mycolic acids are long-chain fatty acids (C70-C90) and they are part of the charasteris-
tic mycobacterial cell wall [5, 54]. The general structure of all mycobacterial mycolic
acids contains a C26 fatty acid chain, which is condensed with a longer and more variable
fatty acid [54]. Mycolic acids in mycobacterial cell walls are bound to arabinogalactan
polysaccharide layer, which is linked to the peptidoglycan layer [60]. These were the first
to be the only mycolic acids present in mycobacterial biofilms. However, mycolic acids
are also secreted by mycobacteria and they are present in biofilms also extracellularly.
The secreted ones are referred to as free mycolic acids [81]. For example M. tuberculosis
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biofilms are rich in extracellular free mycolic acids [3]. Changes in the environmental
conditions affect the structures of mycolic acids. M. smegmatis residing in biofilms pro-
duces shorter ((C56-C68)) mycolic acids than the planktonic bacteria [5].
The synthesis of mycolates, which are the esters of mycolic acids found in the my-
cobacterial cell wall, is modulated by GroEl1 [5]. The M. tuberculosis mutants with
defects in mycolate synthesis have attenuated phenotypes. Short-chain mycolates are up-
regulated during biofilm formation [5]. GroEL1 associates with KasA, which is also in-
volved in the synthesis of mycolic acids. Biofilm formation is linked to higher production
of short-chain fatty acids [5].
Mycobacteria have two GroEL paralogs. GroEL2 is essential for survival and it has a
more typical chaperone structure with a glycine-methionine-rich C-terminus. GroEL1 on
the other hand has a histidine rich C-terminus and it is not required for cell survival [5].
Similar GroEL1 has also been found in Corynebacterium and Nocardia and they also have
mycolic acids in their cell walls so it is possible that they have similar regulation of my-
colic acids biosynthesis [5]. In M. tuberculosis both of these GroEL paralogs are induced
during heat shock, oxidative stress response and macrophage infection [5].If biofilm for-
mation is a typical stress response of mycobacteria, then the upregulation of these genes
could be linked to biofilm formation. Loss of GroEL1 in M. smegmatis does not affect
planktonic cells or surface attachment, but it prevents the biofilm maturation [5].
KasB is only required to add the last ethyl group to mycolic acids in mycobacteria.
KasA, which associates with GroEl1, is a close homologue of kasB. Both kasA and kasB
are conserved in M. marinum and M. tuberculosis and their functions are also conserved
[36]. In M. marinum mutation in kasB grow poorly in macrophages, but normally in vitro.
The mycolic acids produced by these mutants are 2 to 4 carbons shorter and the levels of
keto-mycolates are reduced [66]. Even though these changes are small, they increase the
cell wall permeability massively leading to higher susceptibility to lipophilic antibiotics
as well as the host immune system. The more permeable cell wall allows host’s lysozyme
enter the bacterial cells [66]. The mutants are also unable to form cords. These defects can
be rescued with M. tuberculosis kasB, but not with kasA. Expression of kasA slows down
the growth rate in both liquid medium and on agar [66]. Corresponding mutation in M.
tuberculosis kasB causes similar alterations in the cell wall and a significantly attenuated
infection in mice [82].
Free mycolic acids are an abundant component of the M. smegmatis biofilms in the
later stages of the bacterial growth [81]. They are also abundant in M. tuberculosis pel-
licles [3]. However, the free mycolic acids found in M. smegmatis and M. tuberculosis
biofilms are structurally different, even though the biofilms appear morphologically sim-
ilar [6]. Since certain components of biofilms are linked to pathogenicity, it is possible
that these structural differences in free mycolic acids affect the difference in virulence
between M. smegmatis, which is not pathogenic, and M. tuberculosis, which is highly
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pathogenic. On the other hand, purified free mycolic acids from M. tuberculosis do not
induce a proinflammatory response in macrophages [6], suggesting that free mycolic acids
do not interact directly with macrophages or the response requires another component.
Trehalose dimycolate
In detergent free in vitro cultures M. tuberculosis forms cord structures. The cords are
rich in trehalose dimycolate, which is an extracellular glycolipid found in mycobacterial
biofilms [81]. This glycolipid induces granuloma formation in animal models and mutants
with defects in cording are unable to cause a chronic and lethal infection, even though the
initial replication is normal [83]. Disruption of trehalose dimycolate synthesis causes
severe defects in biofilm development in M. smegmatis. Similar effects are most likely
seen inM. tuberculosis, since trehalose dimycolate is the precursor of mycolic acids and
the pathways of mycolic acid synthesis are closely related between M. smegmatis and M.
tuberculosis [81]. Trehalose dimycolate is required for cording and normal pathogenesis
in M. tuberculosis, but mutants with low levels of trehalose dimycolate can still survive.
In M. smegmatis the drug tolerance correlates with induced synthesis of free mycolic
acids [81].
Trehalose dimycolate is the precursor of free mycolic acids, but only newly synthe-
sized trehalose dimycolate can be used as a precursor [81]. This is most likely due to
cellular localization. The enzyme responsible for production of free mycolic acids is hy-
pothesized to be located in the periplasmic space between the inner and outer membranes.
The enzyme can only convert molecules located in the same cellular location and the pre-
existing trehalose dimycolate is integrated into the outer cell wall [81]. Also the free
mycolic acids are produced by other pathways as well since disruption of the trehalose
dimycolate synthesis only reduces the levels of free mycolic acids [81]. The existence of
several production pathways is often an indication that the particular molecule is impor-
tant for the cell’s survival.
Extracellular DNA
Extracellular DNA (eDNA) is an found in many non-mycobacterial biofilms [63]. It was
first reported by Whitchurch et al. [84] in Pseudomonas aeruginosa biofilms. In other
bacteria eDNA has several important roles [63]. In P. aeruginosa it is known to facilitate
cellular aggregation [85] and spatial self-organization [86]. eDNA can also be transferred
horizontally [87]. The horizontal transfer could be used to spread antibiotic resistance
within the biofilm. In Vibrio cholerae eDNA contributes to nutrient acquisition, biofilm
architecture, detachment from the biofilm and colonization in the new location [88]. Since
eDNA helps to hold the biofilm structure together, it also protects the bacteria residing in
within the biofilm from antibiotics and detergents.
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It is not yet known how eDNA is generated. The eDNA production mechanisms can
be divided to two groups; cell lysis dependent and cell lysis independent mechanisms. In
cell lysis dependent pathways some of the bacteria sacrifice themselves for the benefit of
the colony. This has been shown in P. aeruginosa biofilms, where the cell lysis dependent
eDNA production is prophage-mediated and controlled by quorum sensing [89]. In both
P. aeruginosa and M. avium subsp. hominissuis the eDNA was found to be similar to the
genomic DNA, supporting the theory of cell lysis dependent eDNA production [63,89]. If
the eDNA production pathway s independent of cell lysis, the eDNA has to be transported
to matrix. there are several studies also supporting these mechanisms [63]. Most likely
the production pathway depends on the bacterial species and on the growth conditions.
Distinct wrinkling appearance of mycobacterial biofilm has been linked to greater
eDNA production [63]. In Bacillus subtilis biofilms the wrinkling pattern was linked to
cell death [90]. Cell death would release eDNA into the biofilm and therefore there might
also be a link between wrinkled structure and eDNA in B. subtilis biofilms. M. marinum
produces little eDNA when compared to other non-tuberculous mycobacterial strains [63].
At least in M. avium subsp. hominissuis the amount of eDNA is not directly proportional
to bacterial count, since the bacterial count did not vary a lot between day 1 and day
7, but the amount of eDNA had increased massively [63]. Possibly each lysed bacteria
contributes their genomic DNA to the biofilm matrix and as time passes the eDNA is not
degraded but accumulates. The bacterial count has a limit set by the growth conditions,
but most likely the eDNA does not have a maximum limit as long as the biofilm colony is
functional.
Since DNase is known to disrupt biofilms, it could be combined with antibiotics to
improve their effectiveness when treating mycobacterial infections. An inhaled DNase
adjuvant has already been approved for treatment of cystic fibrosis [63].
2.6 MycoMar T7
MycoMar T7 is a mariner-based transposon system and it contains T7 promoters promot-
ing the transcription of the adjacent chromosomal DNA [91]. The transposon is flanked
by 29 base pair repeats and the T7 promoters are recognized by T7 RNA polymerase,
which is a very active enzyme [92,93]. Therefore the phage can both interrupt the coding
sequence and induce overexpression of the adjacent DNA segment. The result depends
on the insertion site. MycoMar T7 integrates to the genome randomly.
The phage is designed to lyse mycobacteria at around 30 ◦C and integrate at 37 ◦C. It
contains the kanamycin resistance gene as a selection marker. Kanamycin, hygromycin
and streptomycin are the most commonly used antibiotics as selection markers in my-
cobacteria [8]. Kanamycin is often favored because of its high stability and low cost.
Spontaneous mutations resulting in kanamycin resistance are also quite rare in M. smeg-
matis, which is often used due to its short generation time [8].
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3. MATERIALS AND METHODS
In this experiment several screens were conducted in order to find biofilm mutant M.
marinum strains. Eventually six mutants were chosen and their growth rates were deter-
mined. The phage stock preparation and transduction protocol were adapted from Murry
et al. 2008 [94]. The MycoMar T7 phage used for transductions was received from Eric
Rubin Lab, Harvard.
3.1 Phage stock preparation
Mycobacterium smegmatis ATCC-700084 (ATCC, U.S.) was grown on a LB plate at
37 ◦C for several days. The LB plate was prepared from LB broth with agar (Sigma-
Aldrich, U.S.), which was dissolved in sterile H2O according to instructions. M. smeg-
matis was then inoculated from the plate to 1.5 ml of Difco Middlebrook 7H9 broth
(BD, U.S.) growth medium as triplicates. The 7H9 growth medium contained 0.4 %
of glycerol, 10 % of Middlebrook ADC enrichment (BD, U.S.) and 0.05 % of Tween R©80
(Sigma-Aldrich, U.S.) dissolved in sterile H2O. The M. smegmatis cultures were grown
for 24 hours at 37 ◦C and 225 rpm on a CERTOMAT R© RM shaker (B. Braun Biotech
International, Germany) after which one of them was chosen for further dilution. 10, 15
and 20 µl of the chosen M. smegmatis culture was diluted to 10 ml of the 7H9 growth
medium. These were grown for 24 h at 37 ◦C and 225 rpm on a shaker before washing
and plating.
10-fold dilutions of the MycoMar T7 phage were prepared to a volume of 50 µl of
MP buffer. MP buffer contained 50 mM Tris-HCl, 150 mM NaCl, 10 mM MgSO4 and
2 mM CaCl2 dissolved in sterile H2O. The absorbance at 600 nm was measured from the
M. smegmatis cultures and a culture with absorbance between 0.8 and 1.2 was chosen.
This culture was then washed twice with MP buffer and with centrifuge settings of 3 min
at 10 000 g. After the second wash M. smegmatis was concentrated according to formula:
concentrationfactor =
3.2
OD600
, (3.1)
where OD600 is the absorbance at 600 nm. The formula is derived from empirical experi-
ence of Hammarén, M., University of Tampere.
100 µl of the concentrated M. smegmatis culture was mixed gently with each of the
50 µl phage dilutions. Each mixture was mixed with 3.5 ml of top agar and poured on a
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15 cm LB plate. The top agar contained 0.6 % (w/v) of low gelling temperature agarose
(Sigma-Aldrich, U.S.) and 2 mM of CaCl2 in 7H9 broth with 0.4 % of glycerol but without
Tween R©80 and enrichment. The plates were incubated for 2 days at 29 ◦C.
Another set of LB plates containing M. smegmatis in top agar were prepared, but these
plates did not contain the phage. Several plaques were patched to these new plates by
touching the plaque with a pipet tip, then pipetting back and forth in 50 µl of MP buffer.
Then a 10 ul drop was pipetted onto the plate. This was repeated for 9 plaques. Two
identical LB plates were prepared in this manner. One was incubated at 29 ◦C and the
other at 37 ◦C for 2 days.
A clone which formed plaques only at 29 ◦C was chosen and excised from agar with a
sterile blade. The excised agar was incubated in MP buffer at 4 ◦C for 2 hours after which
the agar was crushed and centrifuged at 200 g for 2 min. The supernatant containing
the phage was collected and 10-fold dilutions were made from it. These dilutions were
then mixed with M. smegmatis and plated in top agar as previously. The plates were
incubated at 29 ◦C for 2 days. A dilution with nearly confluent plaques was chosen for
phage production.
Seven plates with the chosen dilution were prepared as previously, but this time LB
plates were not used. Instead the plates were prepared from Difco Middlebrook 7H10
(BD, U.S.) with 5 % of glycerol and 10 % of Middlebrook OADC enrichment (BD, U.S.).
The plates were incubated at 29 ◦C for 2 days. Each plate was flooded with 3 ml of
MP buffer and the plates were rocked gently for 24 hours at 4 ◦C. The MP buffer was
collected from the plates and passed through 0.2 µm syringe filter. This phage stock was
titered by pipetting 10 µl drops of 10-fold dilutions as triplicates on a plate containing
M. smegmatis in top agar as previously described. The plate was incubated at 29◦ C for
2 days after which the formed plaques were counted to determine the concentration of the
stock.
3.2 Transduction
The concentration of the kanamycin for the transducts was determined by plating two
different concentrations of Mycobacterium marinum ATCC927 (ATCC, U.S.) on plates
with different antibiotic concentrations. The bacterial concentrations were calculated to
be around 10 and 100 cfu/µl with plating volume of 100 µl. The plates with kanamycin
concentrations of 25, 40 and 50 µg/ml were prepared by absorption on 85 mm plates
and one 150 mm plate was prepared by adding 25 µg/ml of kanamycin to agar before
pouring onto plates. Controls without antibiotic were also prepared for each bacterial
concentration.
M. marinum was grown in 7H9 broth containing 10 % OADC and 0.05 % Tween R©80
until absorbance at 600 nm was between 0.8 and 1.0. The M. marinum culture was washed
twice with MP buffer and centrifuged at 10 000 g for 3 min. Then the pelleted culture was
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resuspended in adsorption buffer. The adsorption buffer was prepared from Difco Middle-
brook 7H9 broth according to instructions, but there was only and 0.02 % of glycerol and
no enrichment. 1 ml aliquot was removed to serve as a wild-type control. 10-fold amount
of phage was added to M. marinum for transduction and MP buffer was added to the con-
trol in the same volume to volume ratio. The mixtures were incubated at 37 ◦C for 3 h.
Tween R©80 was added to the concentration of 0.05 % and the mixtures were incubated
for 30 min at 29 ◦C. The transduction mixture was divided into aliquots of 2 ml, which
were concentrated to half of the volume and stored at -80 ◦C. To determine the correct
dilution for the desired plating density the transducts were titered as 10-fold dilutions on
7H10 plates containing 50 µg/ml kanamycin. These plates were incubated at 29 ◦C for
7 days.
The transducts were plated in the chosen dilution on 7H10 plates containing 50 µg/ml
kanamycin and incubated at 29 ◦C for 2 weeks. Small single colonies were picked at
different time points during the second week to 96 well plates containing 7H9 broth with
0.05 % of Tween R©80, 0.4 % of glycerol and 50 µg/ml of kanamycin. The 96 well plates
were incubated at 29 ◦C for a week and then stored at 4 ◦C.
3.3 First and second screens
For the first screen the transduct colonies were transferred by pipetting 5 µl from each
well of the original 96-well plate set to a corresponding well in the second set of 96-well
plates containing 0.2 ml of biofilm medium. The biofilm medium had a 7H9 broth base,
and it contained 0.05 % Tween R©80, 0.4 % glycerol and 5 % of OADC enrichment. The
wild-type M. marinum control prepared alongside the transduction was used as a control.
The plates were wrapped in parafilm and incubated at 29 ◦C for 5 weeks. Once a week the
plates were viewed with a Zeiss Stemi 2000 microscope (Zeiss, Germany) to distinguish
the mutants with seemingly different biofilm production. The differences in the biofilm
formation were approximated and the ones unable to form the pellicle or with otherwise
abnormal biofilm structure were chosen for the second screen.
For the second screen 100 µl of the chosen mutants were taken from the original 96-
well plates and diluted to 4 ml of biofilm medium in cell culture tubes. One control tube
with wild-type M. marinum was also prepared. The cultures were incubated at 29 ◦C with
closed caps. The growth was monitored during the first month of incubation. The cultures
were stored at the incubator. The transducts that had grown clearly visible biofilms were
chosen for the third screen. The other mutants chosen for the second screen most likely
had some growth defects induced by the transposon.
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Table 3.1: The sequences of the MMITS1 primers.
Primer Sequence
Forward 5’-CACCACGAGAAACACTCCAA-3’
Reverse 5’-ACATCCCGAAACCAACAGAG-3’
3.4 Colony qPCR
The species of the mutants was verified with qPCR, since the abnormal biofilm could
also be a sign of a strong contamination. M. marinum specific primers were used. These
primers are designed to pair only with M. marinum DNA and their sequences are pre-
sented in 3.1. The primers were diluted from stock to concentrations of 10 µM.
A fresher M. marinum culture was prepared for control. M. marinum was streaked from
the 7H10 plate to 10 ml of 7H9 broth with ADC enrichment and 0.05 % Tween R©80. The
culture was incubated at 29 ◦C and three days later it was diluted so that the absorbance
at 600 nm was 0.07. The diluted culture was incubated at 29 ◦C for a week. This culture
was used in the qPCR also as a 1:10 dilution.
The reaction mixture of the qPCR is presented in table 3.2. A master mix containing
everything but the sample was prepared and pipetted on a 96-well plate. Sterile water was
used as a negative control. The fresher M. marinum culture was used as a species reference
control and the species of the older wild-type control was also determined in a similar
fashion as the mutants. Two replicates were prepared from all samples and controls. The
samples were added by pipetting 1 µl from the culture directly to the well containing
the qPCR mixture. The plate was sealed with a transparent film and centrifuged for 2
min at 2 000 g and 4 ◦C. The program is presented in table 3.3 and it was run on BIO-
RAD CFX96 cycler. The standard deviations for threshold cycles were calculated with
Microsoft Excel.
Table 3.2: The reaction mixtures of colony qPCR and bacterial count determination. The arrows
represent forward and reverse primers.
Component Colony qPCR qPCR for bacterial
(µl) count (µl)
Sensifast NO-ROX SYBR, 10 10
Green Master Mix
Primer MMITS1→ 0.8 0.8
Primer MMITS1← 0.8 0.8
Sterile H2O 7.4 5.4
Sample 1 3
Total volume 20 20
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Table 3.3: The program for qPCR. The melting curve analysis at the last step was measured
between 55 and 95 ◦C with 0.5 ◦C intervals.
Step Time Temperature Fluorescence detection
1 3 min 95 ◦C
2 5 s 95 ◦C
3 10 s 65 ◦C
4 5 s 72 ◦C Yes
5 Go to 2 39 times
6 Melting curve analysis
3.5 Third screen
The cultures for the third screen were prepared and incubated in a similar fashion as the
cultures in the second screen. 100 µl of the second screen culture was diluted to 4 ml
of biofilm medium containing 50 µg/ml of kanamycin. The wild-type control was grown
without kanamycin. Due to the seemingly slow growth rate of the mutants, seven repli-
cates were prepared of each mutant and also of the control. One set of all mutants and the
control was also prepared in the richer 7H9 broth containing 10 % of ADC enrichment.
The cultures were incubated at 29 ◦C with caps closed. After six week incubation one
culture tube of each mutant and the control was used for analysis. The culture was ho-
mogenized, 1 ml was taken for the crystal violet staining, 2 ml for qPCR and 0.5 ml for
DNase treatment. The aliquots were stored at 4 ◦C.
Crystal violet staining
The crystal violet protocol was adapted from Carter et al. 2003 [59]. The 1 ml samples
were centrifuged at 10 000 g for 3 min and the supernatant was removed. The pellet
was resuspended in 1 ml of Gram’s Crystal Violet Solution (Sigma-Aldrich, U.S.) and
incubated for 15 min. Then the samples were centrifuged again with same settings and
the crystal violet solution was removed. The samples were then washed four times with
purified water. After the fourth wash the sample was resuspended in 95 % ethanol and
incubated for 10 min. The cell debris was centrifuged to the bottom and 200 µl of the
ethanol solution was pipetted on a 96-well plate as two replicates. The absorbance was
measured at 600 nm with EnVision 2104 Multilabel Reader (PerkinElmer, U.S.).
Standard curve
A standard was prepared for qPCR to determine the bacterial count. M. marinum was
grown in 7H9 broth containing 0.05 % of Tween R©80 for two days at 29 ◦C. The ab-
sorbance was measured at 600 nm and the bacterial count approximated from it according
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to formula:
CFU/µl = 276165 ∗OD2600 − 2470.7 ∗OD600 + 21389, (3.2)
where OD600 is the absorbance at 600 nm. The equation is from the Master’s thesis of
Milka Hammarén [95]. 2 ml of the culture was then pelleted and frozen at -80 ◦C.
DNA isolation and qPCR
2 ml aliquots of the mutants were pelleted, the supernatants removed and the pellets was
frozen at -80 ◦C. The frozen mutant pellets and the standard curve pellet were then resus-
pended in 1.5 ml of TRI reagent for DNA-RNA co-extraction (MRC, USA) and homog-
enized with PowerLyzer24 bead beater (Mobio, USA) in three 20 s cycles at 3 200 rpmi
with 30 s pauses in between. Then the samples were sonicated in an m08 water bath
(FinnSonic, Finland) for 9 min and centrifuged at 4 ◦C 12 000 g for 10 min. 1 ml of the
homogenate was taken, RNA was removed according to the manufacturer’s protocol and
the DNA was extracted according to the manufacturer’s alternative protocol. The purified
DNA was resuspended in 50 µl of nuclease free water. The DNA concentrations were
measured with NanoDrop 2000 (Thermo Scientific, U.S.). The standard curve was pre-
pared by diluting the purified standard DNA in ten-fold dilutions. The bacterial counts
were then determined with qPCR with the same protocol as described for colony qPCR
and the standard curve as reference. The Bio-Rad CFX Manager was used to determine
the bacterial concentrations of the mutant samples based on the standard curve.
DNase treatment
The 500 µl taken for the DNase treatment was centrifuged at 10 000 g for 3 min and
the pellet was resuspended in 400 µl of DNase I buffer containing 2.5 mM of MgCl2.
The amount of DNase I (Thermo Scientific, U.S.) was approximated based on the qPCR
results of the previously run samples and the size of the M. marinum genome according
to the formula:
VDNase I =
CFU ∗NMm
1000 ∗Npg ∗ Vsample, (3.3)
where VDNase I is the amount of DNase I needed (µl), CFU is the bacterial count ac-
cording to the qPCR (CFU/µl), NMm is the number of base pairs in M. marinum genome,
Npg is the number of base pairs in 1 pg of DNA and Vsample is the volume of the sample
(ml). The amount of basepairs in M. marinum genome is 6 636 827 bp [96] and 1 pg
of DNA contains 978 Mbp [97]. The results were rounded up to the next full µl. Since
the wild-type required significantly larger volume of the enzyme, the DNase I buffer was
added as more concentrated so the DNase I would dilute it to the correct concentration.
The bacteria were incubated with DNase I for 2 h at 37 ◦C after which the DNase I was
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inactivated at 70 ◦C for 10 min. The samples were pelleted, the supernatant was removed
and the pellets were stored at -80 ◦C. The DNA was extracted as previously, except the
purified DNA was diluted to 25 µl of nuclease free water. The bacterial concentrations of
the DNase I treated samples were analyzed with qPCR as previously described.
Protocol alterations for the second time point
The crystal violet staining, DNase I treatment and the qPCR analysis was repeated for
another set of tubes after 8 week incubation. The same protocol was followed with a few
exceptions. In the crystal violet assay a ten-fold dilution was prepared from the ethanol
solution of wild-type control and the absorbance was also measured from this dilution.
The qPCR analysis was conducted for all the samples at the same time, so the amount of
DNase I added to the samples was based on the previous results and therefore the added
volumes were exactly the same as previously. Also the samples were centrifuged and the
supernatant was removed before the DNase I was inactivated.
Analysis of the results
The results were analyzed on Microsoft Excel. A concentration factor was calculated for
all DNA extractions by formula:
CF =
Vsample
VDNA
, (3.4)
where CF is concentration factor, Vsample is the volume taken from the culture and VDNA
is the volume where purified DNA was resuspended. The concentration factor was com-
pared to the one calculated for the standard curve and the starting quantity received from
the Bio-Rad CFX Manager was adjusted accordingly to get the bacterial count of the
original culture.
The amount of biomass per bacteria was calculated with formula:
biomass/bacteria =
CV
bacterial count
, (3.5)
where CV is the absorbance measured in the crystal violet assay and bacterial count is the
bacterial count of the original culture calculated from the DNase I treated samples. The
amount of eDNA/bacteria was calculated with formula:
eDNA/bacteria =
DNAALL
bacterial count
− 1, (3.6)
where DNAALL is the bacterial count received from the sample not treated with DNase I
and the bacterial count is the bacterial count of the original culture.
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3.6 Glycerol stock preparation
The mutants and the control prepared alongside transduction were grown at 29 ◦C on
24-well plates in 1 ml of 7H9 broth containing 10 % of ADC enrichment and 0.05 % of
Tween R©80 for 1 week. Images were taken f the wells before the stocks were prepared.
Each well was homogenized and diluted to half with 40 % glycerol solution. The diluted
glycerol cultures were stored in -80 ◦C.
3.7 Growth rate and growth curves
Pre-cultures of the mutants and the control were prepared by streaking bacteria from a
7H10 plate to 9 ml of 7H9 broth containing 0.05 % of Tween R©80. The pre-cultures were
incubated at 29 ◦C for 3 days. On the third day the cultures were let to settle for 10 min
and 5 ml of the top phase was taken. The pre-culture was added to cell culture tubes
containing 5 ml of the same 7H9 broth until the absorbance at 600 nm of this prepared
culture was 0.07. Three replicates of each mutant and the control were prepared. The
cultures were incubated at 29 ◦C for 5 days. Each day the absorbance at 600 nm was
measured and three different ten-fold dilutions of each tube were plated. The cultures
were mixed properly before the absorbance was measured. The plated dilutions ranged
from 1:102 to 1:105. The plated volume of each dilution was 10 µl.
A set of bottle cultures was also prepared from the same pre-cultures. The pre-culture
was diluted to 9 ml of the same 7H9 broth to reach 0.07 absorbance at 600 nm. These
cultures were grown in cell culture bottles at 29 ◦C for 4 days. Then the cultures were
settled for 10 min and 5 ml of the top phase was collected. The absorbance was measured
from the top phase and then ten-fold dilutions were plated similarly as from the tube
cultures. The plates from both tube and bottle cultures were counted 4 days after plating.
The growth rates were determined based on the results of three days growth in cell cul-
ture tubes. The smallest dilutions with separate colonies on the plate was used as a basis
for the bacterial count calculations. The absorbance values and the bacterial counts were
plotted to graphs on Microsoft Excel. The software was used to draw linear trendlines and
determine their slopes. The correlations between the absorbance values and the bacterial
counts were also calculated. When the cultures tubes and bottles were compared to one
another, the ratio between the optical density and the bacterial count was calculated for
each culture tube separately and then average was taken from these results.
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4. RESULTS AND DISCUSSION
In this chapter the results are presented and discussed in the order in which they were
obtained. Therefore the chapter follows the same order of presentation as the previous
chapter.
4.1 Phage stock preparation and transduction
The phage production was conducted in M. smegmatis due to its faster growth rate and
lower pathogenicity when compared to M. marinum. The concentration of the kanamycin
had to be adjusted since there was growth on the control plates containing kanamycin
and the wild-type M. marinum. Clean control plates were achieved with concentration
of 50 µg/ml. The kanamycin seemed to also work better when it was absorbed to the
plate instead of mixing it with the 7H10 solution before the plates were poured. The
kanamycin was possibly sensitive to high temperature or it did not mix properly with the
agar solution. By absorbing the kanamycin to plates the concentrations are most likely
higher closer to the agar surface and lower at the bottom. The same concentration was
used throughout the experiment with both liquid and agar cultures.
For plating of the transducted mutants a dilution of 1:100 was chosen. This concen-
tration gave enough colonies on the plate, but the colonies remained mainly separate.
The more diluted plate cultures grew barely at all, suggesting a possible link to quorum
sensing.
There is no approximation in the literature about how many of the M. marinum genes
are related to the biofilm formation. As described in chapter 2, the biofilm formation in
M. marinum is a complicated process involving several metabolic pathways, which is also
reflected in the amount of different components found in these biofilms. There are over
5 400 predicted coding sequences in the M. marinum genome [48]. We could assume that
20 % of these genes affect the appearance of the biofilm. Even though the insertion of the
MycoMar T7 is random, there may still be some hotspots for the insertion, which would
lead to mutant strains with similar or same mutations. Since there was no knowledge
about the actual number of biofilm related genes nor about the insertion hotspots, 3 500
separate colonies were picked from the plates to ensure there would be at least a few
different biofilm mutants.
It was hypothesized that mutant strains with biofilm defects would be smaller, since
they form less matrix around them and the small size would mean they became visible
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Figure 4.1: All the biofilm producing cultures from the second screen. 4H is an example of the
non-growing mutants. WT stands for wild-type.
slightly later than others. Therefore the colonies were picked 10 days after plating and
the picked colonies were all relative small.
4.2 First and second screens
In the first screen only around one tenth of the mutants grew at all. This is a very low
percentage and suggests some kind of systematic error. The most likely explanation is
that the small colonies that were picked from the plates had growth defects caused by the
random mutation and they were therefore unable to grow in the biofilm medium, which
had fewer nutrients than the typical growth media. 58 mutants with seemingly abnormal
biofilms were chosen for the second screen.
In the second screen once again most of the mutants did not grow at all. Ten out of 58
mutants produced visible biofilms and these biofilms and the control are shown in figure
4.1. The figure also shows one of the mutants that did not grow at all in this screen. The
mutants that produced biofilm had produced visible biofilms already after one month. The
incubation was continued even after this hoping some of the other mutants would grow
visible biofilms as well, but they did not.
One of the mutants, 12G, had a different coloration and the structure of its biofilm
was also visibly different. The mutant was suspected to be contamination instead of M.
marinum. The colony qPCR was used to find out whether there indeed was M. marinum
present in the cultures or if the growth was mainly contamination.
4. Results and discussion 36
Table 4.1: The means of the threshold cycles and the standard deviations from the colony qPCR.
WT stands for fresh wild-type M. marinum culture, WT 1:10 for a 1:10 dilution of the same culture
and WT CTRL for the wild-type control grown alongside the mutants.
Sample Mean of the threshold cycles Standard deviation
WT 20.53 0.06
WT 1:10 22.68 0.03
WT CTRL 15.43 0.67
2D 14.92 0.40
3E 14.67 0.13
6D 14.32 0.08
6F 16.67 0.48
7G 15.03 0.19
7H 4.72 0.38
8H 10.12 6.60
11A 14.70 0.16
11F 10.69 6.59
12G 36.16 0.02
4.3 Colony qPCR
The primers used in all qPCR assays were designed for the M. marinum 16S-23S ITS
sequence [28]. They are supposed to recognize only M. marinum DNA. All M. marinum
bacteria should have the same number of copies of the 16S-23S ITS sequence and there-
fore it can be used to quantify the number of bacteria present in the sample. The threshold
cycles can be used to approximate the number of bacteria in the sample and low threshold
cycles stand for high number of M. marinum DNA. However, in this colony qPCR the
sample was not homogenized nor the DNA purified, so the amounts of accessible tem-
plate are different in all samples and due to the uneven distribution of the template, the
results cannot be used to quantify the bacterial count. However, low threshold cycles still
suggest high M. marinum content. The threshold cycles of the colony qPCR are presented
in table 4.1.
As can be seen from the table 4.1, some of the standard deviations are quite high,
which is the result of the differences in the amounts of template. Interestingly, almost
all the samples have lower threshold cycles than the fresh M. marinum controls. This
high amounts of M. marinum DNA show that the biofilm present in the culture is in fact
M. marinum. These results do not, however, rule out that there is some contamination
growing alongside the M. marinum. Only the mutant sample 12G has higher threshold
cycles than the M. marinum controls. This is the same mutant that was suspected to be
contamination and these threshold cycles support that hypothesis. The sample 12G was
therefore left out from the third screen.
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4.4 Third screen
In order to determine, which mutant strains form abnormal biofilms, the amount of biofilm
per bacterium needed to be quantified. Absorbance could have been used, but since it was
likely that the mutants have different growth rates, there would have been a lot of variation
in the bacterial counts. Absorbance is also quite unreliable in low-Tween R©80 cultures,
since the bacteria form clumps and the culture is not homogenic. Crystal violet staining is
often used for biofilm quantification, but the problem with this method is that it does not
stain only the matrix but also living and dead cells [98]. Therefore the stain was used to
quantify the biomass and the results were then normalized with the determined bacterial
count. Since the mutants had previously grown poorly on agar, qPCR was chosen as the
method to quantify the bacterial count.
The protocol for the DNase I inactivation was altered for the second time point. The
samples were centrifuged down and the supernatant removed before the DNase I was in-
activated. The inactivation temperature was so high that it most likely disrupted some of
the M. marinum cells. When the cells were centrifuged afterwards some of the intracel-
lular DNA may have been removed in the supernatant. Though the exact results are not
comparable between the two time points due to slightly different protocols, the mutants
can be organized based on the results and these organizations can be compared between
the two time points. Also the reference culture used for the standard curve most likely
contained significantly less dead bacteria, since it was a lot fresher. If mycobacteria incor-
porates the DNA released from the dead bacteria to the biofilm as eDNA, then this fresher
culture should have remarkably less eDNA and therefore the bacterial count would most
likely be higher in the samples that have been incubated for a longer time. The bacterial
counts are not therefore very reliable, but the standard curve allows the two different time
points to be compared to one another.
The samples were concentrated during the DNA extraction, so the concentration factor
needed to be matched with the concentration factor of the standard curve. The concen-
tration factor for the standard curve was 40 and the concentrations of the other samples
were matched to this. The adjusted bacterial counts of the mutant cultures and the control
are shown in figure 4.2. The figure also has the overall DNA content of the samples. The
scales are logarithmic since both the bacterial count and the DNA content of the wild-type
sample were significantly higher than the mutants. As was expected, the bacterial count
is significantly higher in all samples after 8 weeks. This suggests that some intracellular
DNA probably was lost at the first time point, which was after 6 weeks, rendering lower
bacterial counts. Interestingly the amount of overall DNA is lower after 8 weeks than
it was after 6 weeks, suggesting that some mycobacterial DNA was lost in all samples
during the two weeks between the time points. It is unlikely that this is a pipetting error
since the same trend is seen in all samples. The simplest explanation is that the bacterial
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Figure 4.2: The bacterial count as CFU/µl and the overall DNA content of the samples from the
third screen at both time points. WT stands for the wild-type control grown alongside the mutants.
count has declined and instead of being incorporated into the biofilm, the released DNA
has been degraded.
Figure 4.3 shows the amounts of biomass and eDNA produced by the bacteria in the
third screen. The results have been normalized with the samples’ bacterial count allowing
a better comparison of the biomass and eDNA contents. Without this normalization the
strains with low bacterial count but high biomass production and high bacterial count
but low biomass production would be hard to distinguish from one another. What is
interesting in these results, is that the amount of biomass per bacterium is lower in all
samples after 8 weeks. This suggests that there is either less biomass or more bacteria
than there was after 6 weeks. The bacterial counts were significantly higher at the second
time point, after 8 weeks, due to the improved protocol, so the higher biomass production
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Figure 4.3: The biomass and eDNA production from the third screen at both time points. The
right axis is used for the results after 8 weeks, which was the second time point. WT stands for
the wild-type control grown alongside the mutants.
is probably just a result of the altered protocol.
The altered protocol also affects the results of the eDNA production. Since some of
the intracellular DNA was also lost at the 6 week time point, the amount of eDNA is
actually lower than the results show. According to the graph the amount of eDNA was
significantly higher in all samples after 6 weeks, so this again supports the hypothesis that
some of the intracellular DNA was indeed lost.
At both time points all the mutants had significantly lower bacterial counts than the
wild-type and the overall DNA content was also lower in mutants than in the wild-type.
However, the biomass production was higher in all mutants compared to the wild-type.
The amount of eDNA was also higher in most mutants at both time points, when compared
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Figure 4.4: The linear correlation between eDNA and biomass production at both time points. The
correlation coefficients are shown in the graphs.
to the wild-type. At both time points the mutants 8H, 11A and 11F had the highest eDNA
content and this content was significantly higher than the wild-type or any other mutant.
The same mutants also produced quite significant amounts of biomass and the production
was a lot higher than the wild-type. Even though these highest biomass producers were
also the highest eDNA producers, overall there was no correlation between biomass and
eDNA production at the first time point, but some correlation at the second time point, as
can be seen from figure 4.4. The lack of correlation at the first time point may be caused
by the distorted results of the eDNA content. The bacterial counts shouldn’t have an
effect, since both eDNA and biomass content are achieved by dividing the obtained result
with the bacterial count. However, looking at the lower graph in figure 4.4, the samples
are quite scattered on both sides of the trendline. A third measurement would be needed
before any proper conclusions can be drawn from this data.
The mutant 2D always resembled the wild-type the most. It had the highest bacterial
count out of the mutants at both time points. It also had the lowest biomass and eDNA
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contents. After 6 weeks, at the first time point, the culture of the mutant 2D actually had
less eDNA than the wild-type culture. If the mutant 2D resembles the wild-type enough,
it could be used as a kanamycin resistant control in future experiments. However, in the
second screen this mutant did not form a pellicle, which is a significant difference in the
appearance of the biofilm, when compared to the wild-type. On the other hand, this strain
could be used to study the importance of the pellicle formation.
Another mutant with interesting results is 6F. After 8 weeks the culture contains sig-
nificantly less mycobacterial DNA than any other culture. It also has practically no eDNA
at the second time point, after 8 weeks, even though after 6 weeks there was more eDNA
than in the wild-type sample. The amount of biomass is also completely different between
the two time points. The mutant 6F had the highest amount of biomass after 6 weeks but
the second lowest amount of biomass of the mutants after 8 weeks. Since two different
culture tubes were analyzed at the two different time points, it is possible that these dif-
ferences are results of errors that have occurred during sampling or some other point of
the protocol. Due to the inconsistency of the results, the growth rate of the mutant 6F
was not determined, but the mutant was stored as a glycerol stock for possible further
experiments.
The mutant strains with consistent results at both time points for both biomass and
eDNA production were chosen for the growth rate determination. The most interesting
ones were the high biomass and eDNA producers 8H, 11A and 11F, which differed sig-
nificantly from the wild-type. The 2D was also chosen in order to study its resemblance
with the wild-type further. The mutant 7G had similar amount of biomass at both time
points in reference to the other mutants and the wild-type, but the amounts of eDNA were
not consistent. The mutants 7H and 6D were both in between the high producers and
the control at both time points and their results were also considered consistent, so their
growth rates were also determined.
4.5 Biofilm formation in aerobic conditions
Another interesting factor, which affected the selection of the mutants was the formation
of pellicle. The 24-well plates prepared for glycerol stock preparation were also imaged to
see the differences in the biofilms of the mutants compared to the wild-type. The images
of the biofilms are shown in figure 4.5. The mutants forming pellicles were 3E, 6F, 8H,
11A and 11F. The yellow color is most likely the carotenoid pigment caused by exposure
to the light. Since the mutants were all on the same 24-well plate, they have all had the
same amount of light exposure. Interestingly, some of the mutants have a lot more of this
yellow pigment than the others. It seems that in general the pellicle forming mutants also
produce more carotenoid pigment.
The macrostructures of the mutant biofilms are also different. The mutants, such as 6F
and 8H, contain clear cord-like structures. Some of the mutants, like 7H and 11F, have
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Figure 4.5: Images of the wells containing the mutants and the control. The mutants 3E, 6F, 8H,
11A and 11F had formed pellicles as well as the wild-type control, which is marked WT.
almost billowy biofilm at the bottom. In most of the mutants the biofilm also seems a bit
more scattered and clumpy than in the wild-type.
The pellicle formation was also compared to the results of the third screen. The three
highest biomass and eDNA producers also produced pellicles. The pellicle producing
strains had higher biomass and eDNA content on average than the non-pellicle forming
strains at both time points. The calculated averages are listed in table 4.2. At both time
points the average of the amount of eDNA is around twice as high in pellicle forming
strains. The differences between the averages of amounts of biomass are even higher.
Also after 6 weeks the pellicle forming mutant strains had the highest amounts of biomass
Table 4.2: The averages of the biomass and eDNA contents calculated for pellicle and non-pellicle
forming strains separately. The wild-type control is included in the results as a pellicle forming
strain.
After 6 weeks After 8 weeks
Biomass eDNA Biomass eDNA
No pellicle 2.98*10−4 5 400 2.67*10−5 57
Pellicle 7.63*10−4 11 712 9.40*10−5 113
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per bacterium. However, the wild-type M. marinum had the lowest amount of biomass,
even less than the non-pellicle forming strains.
At the second time point, after 8 weeks, the mutants 8H, 11A and 11F had the highest
amount of biomass / bacterium, but the pellicle forming mutants 6F and 3E had signifi-
cantly less biomass than they had after 6 weeks. Since the mutant 6F also had very low
amounts of overall DNA, eDNA and low bacterial counts, it could be that the particular
culture chosen for the analysis at the second time point had not grown properly for some
reason. It is unlikely that the two week difference between the time points would have an
effect, since the incubation time is so long. The mutant 3E also had relatively low amounts
of eDNA, but the amount of overall DNA and the bacterial count seemed normal, when
compared to the results of the other mutants.
4.6 Growth rate
The strains 2D, 6D, 7H, 8H, 11A and 11F were chosen for the growth rate determination.
The wild-type was also grown as a control. Previously the growth rate and the correlation
between the optical density and the bacterial count have been determined for wild-type
M. marinum at higher Tween R©80 concentrations [95]. Since the Tween R©80 inhibits
biofilm formation, the previously determined correlations most likely won’t apply to the
cultures grown at lower Tween R©80 concentrations.
After three days there was a significant drop in the bacterial counts in all samples. The
drop could be a result of the change of the dilution medium, since on previous days the
growth medium was used for dilution and on the last two days phosphate buffered saline
was used as a dilution medium. However, there should not be this dramatic effect, since
the phosphate buffered saline is used in infections as a dilution medium. All the dilutions
were also carried out within two hours of the first absorbance measurement. Either the
phosphate buffered saline wasn’t what it was supposed to be or the bacteria residing in it
die a lot faster than previously believed. Due to the decline in bacterial counts the growth
rates were determined based on the three first days.
The increase rates of bacterial count and optical density are shown in table 4.3. The
rates have been normalized with the wild-type to make the comparison of the values easier.
In all mutant cultures the optical density increases faster than in the wild-type cultures.
The mutants with the slowest increase in optical density, and therefore the mutants closest
to the wild-type, are mutants 2D and 6D. The strain with the fastest increase in optical
density is mutant 7H with over 20 % faster increase in optical density than the wild-type.
The mutant 2D has only 6 % faster increase in optical density.
The generation times of the mutants vary a lot more than the increase rates of optical
density. The mutants 2D and 11F had faster generation times than the wild-type. The gen-
eration times of the other mutants, however, are significantly slower than the wild-type.
The mutant 6D has the slowest generation time, only 30 % of the wild-type generation
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Table 4.3: The growth rates of the mutants measured as change in bacterial counts and absorbance
in reference to wild-type M. marinum. WT stands for wild-type control, OD for optical density
and BC for bacterial count.
Strain OD BC OD/BC
WT 1.00 1.00 1.00
2D 1.06 1.12 0.95
6D 1.08 0.30 3.64
7H 1.23 0.60 2.07
8H 1.18 0.39 3.04
11A 1.12 0.60 1.85
11F 1.18 1.30 0.91
time. The mutant 8H is not a lot faster, only 39 % of the wild-type generation time.
What really is interesting biofilm-vice, is the relation between the generation time and
the increase rate of optical density. The increase in optical density is caused by both
increase in the bacterial count as well as increase in the amount of biofilm. Since the rates
have been normalized with the wild-type rates, the increase rates closest to 1 are closest
to normal and the increase rates farthest from it are the most abnormal. The strains 2D
and 11F stand out as the strains closest to the wild-type. Both of them have a bit higher
increase rates of both optical density and bacterial count as compared to the wild-type.
Also for both strains the increase rate of optical density is slightly slower than the increase
rate of bacterial count. It seems that they produce somewhat similar amounts of biofilm
per bacterium as the wild-type. The faster generation time may make them seem like
more efficient biofilm producers, since the optical density increases faster. However, the
increase in bacterial count accounts for the faster increase in optical density.
The rest of the strains seem like more efficient biofilm producers than the wild-type,
since their optical density increases significantly faster than the bacterial count. This is
consistent with the results of the third screen. The two strains with the fastest increasing
optical density, when compared to the bacterial count, are mutants 6D and 8H. In both
cases the bacterial counts are rising extremely slowly, which mainly accounts for the
difference when compared to the wild-type.
The correlation between the bacterial count and the optical density was also studied.
The correlation coefficients and the plotted graphs are shown in figure 4.6. There is little
to no correlation between the optical density and the bacterial count in strains 6D, 8H and
11A. The highest correlation coefficients are found in mutants 2D, 7H and 11F as well
as the wild-type. It seems that for some of the strains an equation describing the relation
between the optical density and the bacterial count could be determined with a few more
replicates for each time point.
The bacteria was also grown as bottle cultures to compare the effect of the culture
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Figure 4.6: The correlations between bacterial count and optical density within the first three days.
WT stands for wild-type control. The correlation coefficients are listed in the bottom right corner.
vial and the daily measurements of optical density, which required proper mixing of the
culture. The bottles were grown undisturbed for four days at the same conditions as the
culture tubes previously described. It is probable that the daily mixing affected the biofilm
formation somehow. The results of the comparison are shown in table 4.4.
There are only small differences in the optical densities between bottle and tube cul-
tures. In general the optical densities are a little higher in the bottle cultures. This could
possibly be a result of biofilm breakage caused by the daily mixing in the tube cultures.
The bacterial counts are also lower in the tube cultures than in bottles, except for the
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Table 4.4: The optical densities and the bacterial counts measured from the bottle and tube cultures
on the fourth day. The values of optical density and bacterial count from the culture tubes are
averages of the three tubes. WT stands for wild-type control. OD stands for optical density and
BC for bacterial count.
Strain OD OD BC BC OD/BC OD/BC
in a bottle in a tube in a bottle in a tube in a bottle in a tube
WT 0.42 0.43 1 550 1 800 0.00027 0.00030
2D 0.52 0.44 1 750 530 0.00030 0.00095
6D 0.53 0.46 1 350 130 0.00039 0.00382
7H 0.49 0.45 1 400 200 0.00035 0.00281
8H 0.50 0.45 1 000 500 0.00050 0.00104
11A 0.51 0.45 1 600 200 0.00032 0.00311
11F 0.42 0.45 950 870 0.00044 0.00053
wild-type. However, the differences of bacterial counts between bottles and tubes are
much greater than the differences in optical densities. The drop in bacterial counts, which
was observed in the culture tubes, possibly also occurred in the culture bottles. The bac-
terial counts are so much higher in the culture bottles that if a drop in bacterial counts
occurred, ether it was significantly smaller in culture bottles or the peak of the bacterial
counts was a lot higher in them.
The bacterial counts in the wild-type tube cultures are a bit higher than in the culture
bottle. It seems that the wild-type M. marinum grew slightly better in the culture tube.
The ratio between the optical density and bacterial count is very similar in both cultures,
suggesting similar biofilm formation. The mutant strain 11F also had similar results on
the fourth day in both tube and bottle cultures. Interestingly this mutant grew poorest out
of all strains in the culture bottles, but was second best growing in the tube cultures. It
seems that the daily vigorous mixing affected the wild-type and the mutant 11F less than
others if at all. One explanation could be that they have stronger cell wall structure, which
then tolerates the mixing better. According to the literature the cell wall structure has a
great impact on the structure of the biofilm.
The rest of the mutant strains had significantly lower bacterial counts in the tube cul-
tures than in the bottles, even though the optical densities were similar in both. In many of
these strains there are actually ten-fold differences between ratios of optical density and
bacterial count. With the strain 2D the ratio in the culture bottle is one third of the ratio
in tube cultures. With the strain 8H the ratio in the bottle culture is half of the ratio in the
tube cultures. It could be that these poorly grown strains went into the biofilm producing
mode. The formed biofilm was constantly dispersed, so the bacteria kept producing more
of the biofilm matrix and therefore they weren’t dividing. With this hypothesis the strains,
which were mostly affected by the mixing, have the weakest biofilms. These strains are
the mutants 6D, 7H and 11A. Then the wild-type biofilm and the biofilm of the mutant
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11F would be the strongest ones. However, the experiment should be repeated to verify
the results, since there was only one bottle culture of each of the strains.
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5. CONCLUSIONS
Tuberculosis has infected the mankind for at least 4 000 years. The course of the M. tu-
berculosis infection depends on the host’s immune system, the initial bacterial load and
the bacterial strain. The bacteria is phagocytosed by macrophages and dendritic cells.
Then the bacteria residing in the phagosome inhibit the phagosome maturation and the
macrophage becomes infected. The infected cells aggregate and attract uninfected cells
to the aggregates forming a granuloma. These granulomas are a characteristic sign of
the M. tuberculosis infection. The granulomas protect the bacteria from the host’s im-
mune system, but they also restrict the growth of the bacteria. The bacteria residing in the
granuloma may enter dormancy, establishing a latent infection. If the infection remains
active, the bacteria escape from the granuloma and help to form new granulomas. The M.
tuberculosis growth in lungs causes extensive damage, eventually leading to suffocation.
The main problem with tuberculosis infections is, that they are often resistant to several
antibiotics and require long periods of treatment with several different antibiotics.
The infection mechanisms of M. marinum are very similar to M. tuberculosis and they
share many virulence factors. They have different natural hosts and the generation time of
M. marinum significantly shorter. M. marinum infection in zebrafish has therefore been
used to study these infection mechanisms in a safer and faster way. M. marinum is also
easier to culture since it survives in liquid media. The zebrafish are also an inexpensive
model, which requires relatively small facilities.
The persistent biofilms are believed to be the basis of the antibiotic resistance of my-
cobacteria, like M. tuberculosis and M. marinum. The mycobacterial biofilms can crudely
be divided to two groups based on the location of their adherence. Pellicles are formed
at the air-liquid interphase and they are attached to the sides of the culture and pellets are
formed at the bottom and they are attached to the bottom of the container. The forma-
tion of the biofilm depends on the growth conditions and for many mycobacterial species
nutrient depleted media seems to induce biofilm formation. However, in this experiment
it seemed that M. marinum biofilms were formed significantly faster in richer media. It
could be that the biofilm formation was in fact more efficient in the depleted media, but the
bacterial growth and cell division was completely stalled and therefore the cultures died
before proper biofilm could be produced, so only the strongest mutant strains survived
and produced visible biofilms. This could explain the poor bacterial growth in the first
and the second screen. During the experiment the number of strains reduced from 3 500
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to 9 and finally to 6 for the growth rate measurements. In the first and second screens,
the reduction of the strains was mainly a result of the non-growing cultures instead of
a normal appearance of the biofilms. Therefore it is hard to approximate the mount of
biofilm related genes from these results. However, it seems that all the strains chosen
for the third screen had somewhat abnormal biofilms when compared to the wild-type. It
seems that there are more genes related to the biofilm formation than was approximated
in the beginning of this experiment, since at least 5 strains with clearly abnormal biofilm
formation were found.
The ECM of the M. marinum biofilm contains several different lipids, proteins and
eDNA. In this experiment only the amount of eDNA was studied separately. In the third
screen the amount of DNA was determined before and after DNase I treatment. There
were three mutants, 8H, 11A and 11F, that had significantly more eDNA in the cultures
than any of the others or the wild-type. All of these three mutants also formed pellicles.
The other two pellicle-forming mutants, 3E and 6F, did not stand out as eDNA producers.
In fact there was practically no eDNA found in the mutant 6F culture at the second time
point, but the amount of overall DNA was also low as well as the amount of biomass. It
seems likely that for some reason the particular culture had grown poorly. The results of
the 6F at the second time point should therefore be considered unreliable.
At the first time point in the third screen the pellicle-forming mutants clearly had the
highest amounts of biomass per bacterium. However, at the second time point the amount
of biomass was smaller in mutants 3E and 6F. It could be that there were some problems
also in the 3E culture as well as in the culture of 6F. Another possibility is that the muta-
tions in these two strains are somewhat less stable, resulting in more variable phenotypes.
Since the protocol was improved for the second time point, the results of that time point
should be more reliable than the results of the first time point. However, only one tube
was measured per strain at both time points, which lowers the reliability of the results
greatly. This is why all the mutants with dissimilar results at the two time points were left
out from the growth rate analysis.
The results of the third screen suggest that there might be a correlation between pellicle
formation and higher biomass formation. If this is the case, then the pellicle most likely
contains more biomass per bacterium than the bottom biofilm. On the other hand, the
wild-type M. marinum, which also forms the pellicle, had the lowest amounts of biomass
per bacterium in the cultures. In fact, all the mutants produced more biomass per bac-
terium than the wild-type in both the third screen as well as in the growth rate determi-
nations. The eDNA isn’t stained by crystal violet, so high eDNA content in the biofilm
doesn’t explain high biomass content and there was no correlation between them either,
even though the three highest biomass producers were also the highest eDNA producers.
The current hypothesis is that mycobacteria are either actively dividing or producing
biofilm [55], and the results of this screen seem to support that hypothesis, since the high
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biomass producers had low bacterial counts and vice versa. The high biomass therefore
reflects higher amounts of biofilm matrix, if the bacterial counts are low. It seems that
there might be reverse correlation between the bacterial counts and the biomass content.
The linear correlation between these two, however, is very low. Another option is that
the high eDNA producers, which also have low bacterial counts are dying faster than the
other strains and the DNA released from the dead cells is incorporated to the biofilm.
The amount of biomass also seems to correlate with the optical density to some extent.
The correlation between bacterial count and optical density was actually surprisingly high
even at this low concentrations of Tween R©80. Enough high correlation allows the bac-
terial count to be approximated from the optical density. The equation describing the
relation between optical density and bacterial count should be determined to all mutants
with high enough correlation and the wild-type. These equations could later be used in
infection experiments on zebrafish.
In the third screen mutant 2D resembled the wild-type most, but in the growth rate
determinations mutant 11F had the closest resemblance with the wild-type. The growth
rate was determined in a richer medium, so it could be that the nutrient deprived growth
medium affected mutant 11F more than others. Also the 2D strain does not produce
pellicle, but the strain 11F does. Therefore the mutant 11F might actually work as a
better kanamycin resistant control in future experiments. Mutant 11F was also almost
as resistant to mixing as the wild-type, which was the most resistant out of the tested
strains. This suggests that these two strains have the strongest cell walls, which might
also lead to stronger biofilms. However, the mutation of 11F is not known, so wild-type
control should be used alongside it. The strain 2D could be used to study the effects of
pellicle formation and see how the lack of pellicle in vitro affects the infection outcome
in zebrafish.
If the experiment should be repeated, it would be better to use a richer growth medium
also in the screens, so the effect of the nutrient deprived growth medium could be ruled
out. The mutants grown in richer media were also more likely to grow on agar, so there
would be more reliable and efficient means for bacterial count determination. The qPCR
only measures bacterial content, and if the relation between the eDNA and the bacteral
varies between strains, which is likely in mutant strains, the qPCR becomes very unreli-
able. On the other hand, the qPCR could be used for more reliable eDNA measurement if
the standard was also measured before and after the DNase treatment. Also the colonies
picked from the plates should not be so small. The smaller colonies most likely increase
the risk of growth defects. The results of the experiments are also more worthwhile, if the
strains do not grow unusually slow.
It is likely that only some of these mutant strains harbor a knockout mutation. The
MycoMar T7 phage contains T7 promoters flanking the transposon. The T7 promoter is
highly active, so the adjacent segments of genome are overexpressed. It could be that
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these high biomass or eDNA producers are actually overexpressing the genes close to
the transposon and this overexpression causes the excess biofilm formation. The mutant
2D is more likely to have a knockout mutation, since it does not form the pellicle. Also
it is not known, whether these strains contain only one or several mutations. It is not
only possible, but also likely, that some of these strains actually contain more than one
integrated transposon. Therefore these mutants should be sequenced to determine, what
kind of mutations they have.
The effect of the mutation could be studied further with antibiotics and other biocides
to see if the altered biofilm also alters the resistance to these biocides in vitro. Since the
biofilm is believed to act as a protection against biocides, the strains producing higher
amounts of biomass and therefore also more biofilm matrix, should have higher tolerance
against biocides. The sequencing could also bring more insight to biofilm formation,
possibly revealing new genes and metabolic pathways related to it.
These mutant strains could also be studied in vivo in the zebrafish model. The zebrafish
could be infected with a mutant strain and the infection outcome could be compared to the
wild-type M. marinum. The bacterial loads of the infection could be studied at different
time points post infection. Also the effect of different antibiotics against the infection
could be studied as well as the structure of granulomas. It would be really interesting
to study the correlation between biofilms and granulomas. Does the abnormal biofilm
formation affect the structure and formation of granulomas?
The most interesting results are achieved if the affected genes have orthologues in
the M. tuberculosis genome. If the overexpression of a certain gene results in higher
biofilm formation, could the knockout strain lacking the same particular gene have defi-
cient biofilm formation? The orthologues in the M. tuberculosis genome will also provide
important insight into the metabolic pathways associated with biofilm formation in M. tu-
berculosis and the infection outcomes of these M. marinum mutants in zebrafish may give
more information about the infection mechanisms of M. tuberculosis. The data gathered
from the future experiments of these mutant strains could possibly lead to design of new
and more efficient drugs against mycobacterial infections, including tuberculosis.
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